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Abstract
Background:
Acute pancreatitis (AP) remains a significant cause of human morbidity and 
mortality, and for which therapy remains limited in its ability to prevent the 
development of severe disease. Urgent work is needed to elucidate the 
disease process at the cellular level to identify suitable targets for therapy. 
Extensive research as been undertaken in animal models, which have helped 
clarify the underlying complex cellular mechanisms involved, yet much still 
remains unclear. In particular the use of the hyperstimulation-induced 
animal model, particularly with cholecystokinin (or its analogue caerulein), 
has been controversial in recent years with detractors claiming there is no 
clear relevance to human disease. Work with human tissue is required to 
validate the findings of such animal models of acute pancreatitis. Cell death 
pathways are suggested to play a pivotal role in determining disease 
severity, with apoptosis favouring milder outcomes, and necrosis favouring 
increasing severity. However in recent years it has been suggested that this 
view may be simplistic. The Bcl-2 family of proteins have been found to be 
important regulators of cell death, but there have been no published work 
investigating their action in in vivo pancreatitis. Caffeine has been suggested 
as a potential therapeutic at it inhibits the abnormal Ca2+ signals associated 
with pancreatitis in vitro. However it’s actions have not been tested in vivo. 
Methods:
Experiments using confocal microscopy to test the responses of two 
subtypes of cholecystokinin (CCK-8 and CCK-58), in both isolated murine 
and human isolated pancreatic acinar cells, found both subtypes elicited 
very similar responses in both species. These responses were linked to 
metabolic activity (as measured by increase in mitochondrial NADH) and 
secretion (measured by loss of quinacrine from zymogen granules). These 
results validate continued use of the hyperstimulation model of acute 
pancreatitis.
Results:
Caerulein-induced AP in Bak, Bax and Bcl-2 knockout (KO) mice revealed 
surprising results. Bcl-2 KO had little effect on AP, Bak KO led to less 
severe disease, but no change in apoptosis. Bax KO led to more severe 
disease and early necrosis (first 8hrs), but subsequently increased apoptosis 
at later time points (12-24 hrs). This suggests the current understanding of 
Bcl-2 family proteins is incomplete.
Conclusions:
Caffeine was foimd to have protective effects in caerulein murine AP when 
administered at a concentration of 10 mg/kg, and more so at 50 m g/kg but 
this dose produced severe toxic side-effects. Further work is needed to 
optimise the correct dose and test caffeine metabolites and/or analogues.
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CHAPTER 1 - INTRODUCTION
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1 Introduction
1.1 The burden of human acute pancreatitis
Acute pancreatitis in humans is a common and debilitating condition in 
which inflammation of the pancreas occurs, that can lead to considerable 
morbidity and mortality. Whilst the majority of patients present with mild, 
self-limiting inflammation, in a sizable minority there is severe disease, 
which is associated with multi-organ injury (Pandol et ah, 2007). Currently 
therapy is limited in its ability to stop or reverse the development of a severe 
episode of disease. Patients with acute pancreatitis usually present with a 
short history of severe abdominal pain (typically central), nausea and/or 
vomiting and have a measurable serum amylase at least three times the 
normal upper limit (though values need to be interpreted in the light of onset 
from symptoms) (UK Working Party on Acute Pancreatitis, 2005). Patients 
are admitted for observation and supportive interventions with the intention 
of reducing injury by ameliorating the systemic inflammatory response 
system (SIRS). Patients with severe disease may require transfer of care to 
an intensive care setting. In patients with severe disease the initial clinical 
diagnosis is usually confirmed with a computer tomography (CT) scan, at 
least in part to determine the extent of pancreatic necrosis. Much work has 
been done to identify patients with severe disease early.
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Mortality is higher in patients with necrotising pancreatitis compared to 
those with milder, oedematous pancreatitis (17 percent versus 3 percent), 
and is higher still (approximately 30 percent) in those with infected necrosis 
(Banks and Freeman, 2006)(Pandol et al., 2007). The prevalence of infected 
necrosis has fallen over recent years from 35 percent to nearer 15-20 
percent. This improvement in survival is likely multi-factorial, and is most 
likely to reflect better intensive organ support and the use of CT-guided 
fme-needle aspiration for accurate microbiology sampling in infective 
necrosis (with application appropriate antibiotics). More patients present 
with oedematous pancreatitis than necrotising pancreatitis (85 percent 
versus 15 percent).
The incidence of acute pancreatitis in the UK has historically been show to 
be rising over the last few decades. Three studies have shown this trend: in 
Scotland (between 1984-1995) (McKay et al., 1999) and in the south of 
England (Corfield et al., 1985)(Toh et al., 2000). From these studies the 
incidence of acute pancreatitis in the UK has been shown to range from 150 
- 420 per million population.
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In the USA acute pancreatitis accounts for over 220,000 hospital admissions 
per year, but here the role of alcohol appears to be more substantial, and 
shows a sex preference, being more common among men (Whitcomb, 
2006). Gallstone-related disease is highest among white women over sixty 
years. About 20 percent of adult cases have severe disease and the overall 
mortality is approximately 5 percent (Banks & Freeman 2006).
UK guidelines state that mortality should be less than 10 percent overall and 
less than 30 percent in severe (complicated) pancreatitis (UK Working Party 
on Acute Pancreatitis, 2005). However some specialist units would argue 
that this overall rate should be lower. Changing therapies may contribute to 
a drop in mortality; 19 percent is achievable in patients undergo minimally 
invasive surgical techniques to debride necrotic pancreatitis, rather than 
traditional ‘open’ techniques (Raraty et al., 2010).
1.1.1 Aetiology of human disease
The two commonest aetiological factors associated with acute pancreatitis in 
the western world are gallstone disease and alcohol abuse, though there is a 
myriad of other rarer, and aetiologically disparate, causes (see Table 1.1).
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The fact that so many unrelated aetiologies can lead to the same disease 
strongly suggests a final common pathway(s). The dominance of the two 
major aetiological factors, gallstones and alcohol, differs between 
populations. For example the majority of cases in the USA are attributed to 
alcohol, whilst the majority of cases in the UK are attributed to gallstone 
and biliary disease. In 1979 a study in Bristol reported 4 percent of patients 
having an alcohol aetiology (Trapnell et al., 1979), whilst a contemporary 
study in Atlanta, USA report 92 percent secondary to excess alcohol 
(Satiani et al., 1975) (as reported by Schmid et al., 1999) . In Finland 
between 1970-1989 an increase in incidence from 466 to 734 per million 
population was found to correlate strongly with an increase nationally in 
alcohol consumption (Jaakkola & Nordback, 1993).
In 1901 Opie reported his theory that gallstones caused acute pancreatitis by 
one of two proposed mechanisms (Opie 1901). In the first (Opie 1 or 
common channel theory) it was proposed that gallstones impacted the 
ampulla and an increase in pressure forced bile to reflux into the pancreatic 
duct and that this initiated acute pancreatitis. In the second (Opie 2 or 
obstructed pancreatic duct) there is obstruction at the ampulla but no bile 
refluxing into the pancreatic duct.
15
Duct Obstruction Gallstone obstruction
Focal area of necrosis leading to fibrosis
Congenital abnormalities 
-pancreatic divisum 
-choledochal cyst
Neoplasia
-intra-papillary mucinous neoplasia 
-adenocarcinoma of head of pancreas 
-cholangiocarcinoma
ERCP
Sphincter of Oddi dysfunction
Trauma 
-blunt injury
-surgical injury to pancreas
Toxic/metabolic Alcohol
Drug-induced
-thiazides, azathioprine, steroids, valproate, frusemide 
Hypercalcaemia
Hyperlipoproteinaemia (types I and V) 
Hyperparathyroidism
Scorpion venom
Infection Viral: coxsackie B, CMV, HIV, viral hepatitis, mumps 
Bacterial: mycoplasma, leptospira, salmonella
Fungal: aspergillus, toxoplasma, ascaris
Genetic Familial defects of cationic trypsinogen (N291, R117H) 
Mutation of serine protease inhibitor Kazal type 1 
cystic fibrosis (CTFR gene defect)
Others Ischaemia
-SMA thrombosis/embolism, coronary bypass 
Inflammatory
-primary autoimmune (IgG4-related disease spectrum) 
-secondary autoimmune (polyarteritis nodosa, systemic 
lupus erythematosus, vasculitis, inflammatory bowel 
disease
Idiopathic
Table 1.1: Aetiology of acute pancreatitis (adapted from Dominguez-Munoz 
2005; Carter et al., 2009)
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In support of the common channel theory experimental work in animals has 
shown that bile acids perfused into the pancreatic duct will cause 
pancreatitis (Pandol et ah, 2007) and recent studies have demonstrated
'y,
uptake of bile acids by pancreatic acinar cells with subsequent Ca release 
from the endoplasmic reticulum store coupled with inhibition of calcium 
uptake pumps (Voronina et aL, 2002). The supramaximal level of 
intracellular calcium leads to mitochondrial dysfunction, and the death of 
the cell by necrosis. It is important to note that these animal models of 
disease have yet to be confirmed in human disease.
Gallstone obstruction at the ampulla can cause obstruction of the pancreatic 
duct without bile reflux into the pancreas. Animal models of pancreatic duct 
obstruction without bile reflux (i.e. by ligation of the pancreatic duct) differ 
between animal species as to whether or not pancreatitis is induced, with the 
opossum model being notable for its resultant necrotising pancreatitis (Chan 
and Leung, 2007). Obstruction of the pancreatic duct by malignancy is a 
suspected cause of acute pancreatitis in humans.
Although excessive alcohol intake is a major cause of acute pancreatitis, 
pancreatitis only occurs in a small minority of patients who regularly drink
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excessive alcohol. One suggestion is that excessive alcohol intake increases 
the sensitivity of the pancreas to other aetiological factors and several 
mechanisms are proposed including: ethanol affecting the inflammatory 
signalling system; decrease in the expression of caspases involved in 
apoptosis; decreased microperfusion of the exocrine pancreas and increased 
cathepsin-B activity (Pandol et al., 2007). The combination of these effects 
is to result in increased necrosis when the pancreas is stressed and/or 
damaged. Recently there has been evidence that genetic variations in the 
PRSS1-PRSS2 gene (which codes for cationic human trypsinogen) and in 
the claudin-2 (CLDN-2) gene may be linked with higher risk for both 
alcohol-related and sporadic pancreatitis (Whitcomb et al.5 2012). 
Homozygous (or hemizygous in males) CLDN2 genotype carries the higher 
risk, and may explain while alcohol-related pancreatitis is higher in men 
than women (male hemizygote frequency is 0.26 versus 0.07 in women).
There is experimental evidence that ethanol has more direct actions on the 
pancreas itself, linked to the formation of fatty acid ethyl esters (FAEEs) 
during metabolism of ethanol in the pancreas. In animal models FAEEs are 
capable of producing pancreatic oedema and intracellular trypsin activation, 
and have also been shown to cause sustained increases in cytosolic Ca via 
inositol trisphosphate receptors leading to mitochondrial injury and loss of
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ATP production, predisposing the pancreatic acinar cell to necrosis (Criddle 
et ah, 2006).
1.1.2 Does aetiology influence severity?
Some older studies have previously suggested a greater prevalence of 
increased severity with biliary pancreatitis as opposed to alcoholic 
pancreatitis. However more recent work did not detect any statistical 
difference in severity in acute pancreatitis due to differing aetiologies. One 
study of 190 patients with acute pancreatitis looked at several clinically 
measurable parameters including prognostic scoring, mortality, sepsis, 
jaundice, ileus and pulmonary, renal and cardiorespiratory insufficiency 
(Uhl et ah, 1996) and grouped results into three categories: alcoholic 
aetiology, biliary aetiology and other aetiology. Other than jaundice and a 
transient rise in the liver enzyme aspartate aminotransferase seen in biliary 
aetiology, the course of disease was very similar in all three aetiological 
groups. The authors concluded that after initiation of pancreatitis the course 
was not influenced by the aetiological factor (provided the aetiologically 
was not still present, causing a persistent stimulus).
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Another group looking at 602 patients again found no significant differences 
between aetiological groups with the exception of a higher rate of pancreatic 
pseudocysts in alcoholic aetiology (Lankisch et al., 1996). However this 
finding of increased rates of pancreatic pseudocysts was not seen in other, 
contemporary studies, where rates were the same for differing aetiologies 
(Nguyen et al., 1991).
Interpretation of studies investigating whether aetiology influences severity 
of acute pancreatitis is made difficult by differences between the studies 
themselves; differences in definitions of the various aetiologies; differences 
in collection of data (retrospective, prospective, etc.); and differences 
between specific population groups. However it would seem to be 
reasonable to state that there is no clear difference in the severity of acute 
pancreatitis between groups with differing aetiological causes.
1.1.3 Severity scoring systems
Attempting to identify those patents with severe disease early has led to the 
development of several prognostic scoring systems. The aim is to 
accurately, rapidly, cheaply and safely identify those patients for whom
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therapies for organ support may reduce morbidity and mortality. For scoring 
systems to be applied widely there first has to be an agreement on the 
definition of acute pancreatitis and its sub-types. In this way studies and 
trials can be compared across international centres.
Prognostic scoring systems have been widely employed since Ranson 
published his famous system for scoring patients admitted with acute 
pancreatitis caused by alcohol (Ranson et ah, 1974). This scoring system 
uses easily measured biochemical markers (except for the measurement of 
Blood Urea Nitrogen, which is not routinely available in the UK, though can 
be calculated from serum Urea levels). Imrie further refined this to allow 
application to all cases of acute pancreatitis in the development of the 
Glasgow scoring system (Imrie et ah, 1978) and by Ranson again in 1979. 
The Glasgow score is still widely employed today, as it is easy to calculate. 
Other scoring systems such as the Acute Physiological and Chronic Health 
Score (APACHE)(Knaus et al., 1985)(Dommguez-Munoz et ah, 1993) and 
APACHE-O which combines with BMI (obesity engendering a higher risk 
of severe disease)(Martinez et al., 2006) are not specific to pancreatitis but 
give a detailed measurement of physiological injury. They are wieldy to 
perform and are usually confined to intensive care and research centre 
settings.
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Other scoring systems proposed have been based on radiological criteria 
(Balthazar et al., 1985), simple physiological measures (BISAP score) 
(Layer, 2008)(Papachristou et al., 2010), and measurements of organ failure 
(Marshall score). Persistent organ failure in the first 48 hours has been 
linked to mortality greater than 50% (Buter et al., 2002)(Johnson and Abu- 
Hilal, 2004).
In 1992 an international symposium of experts met in Atlanta, USA and 
produced a clinically based classification system (Bradley EL III, 1993). 
This introduced international uniformity to the classification system, with 
the intention of allowing greater comparison between studies. As well as a 
definition of acute pancreatitis, further definitions were also given for mild 
and severe disease, and the local complications of ‘acute fluid collection5, 
‘acute pseudocysf, ‘pancreatic necrosis5 and ‘pancreatic abscess5. 
Following criticism this classification has since been revised to update the 
terminology and provide simple functional clinical and morphologic 
classifications (Thoeni, 2012)(Vege et al, 2009). The modifications: i) 
address the clinical course and severity of disease, ii) divide acute 
pancreatitis into interstitial edematous pancreatitis and necrotizing 
pancreatitis, iii) distinguish an early phase and a late phase (before/after the 
1 st week) and iv) emphasize systemic inflammatory response syndrome and
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multisystem organ failure. Acute collections in the first 4 weeks are called 
‘acute necrotic collections’ or ‘acute peripancreatic fluid collections’, and 
further sub-divided on presence or absence of necrosis. Once an enhancing 
capsule develops, persistent acute peripancreatic fluid collections are 
referred to as ‘pseudocysts’; and acute necrotic collections, as ‘walled-off 
necrosis’ (which can be sterile or infected). Although it is the only widely 
accepted classification system, it is not without critics and terms abandoned 
by the Atlanta system (such as ‘Phlegmon’) are still found frequently in the 
literature (Bollen et al., 2008). Not all national guidelines for managing 
acute pancreatitis recommend the Atlanta system.
In the last year a new ‘Determinant-Based classification of Acute 
Pancreatitis Severity’ has been published (International Multidisciplinary 
Consultation, 2012). This involved a consultative survey of pancreatologists 
from 49 countries who recommended 4 gradings: i) mild AP- absence of 
both necrosis and organ failure; ii) Moderate AP - presence of sterile 
necrosis and/or transient organ failure; iii) Severe AP - presence of either 
infected necrosis or persistent organ failure; iv) Critical AP - presence of 
infected necrosis and persistent organ failure. It should be noted that these 
gradings may have some use in quantifying results, especially between 
centres, but may be difficult to distinguish in clinical practice.
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1.1.4 Improvements in management of acute pancreatitis
There has been a decrease in morbidity and mortality in acute pancreatitis 
over recent decades. However this is due to improvements in organ support 
and timing of interventions and not to the application of a specific drug 
therapy, which is still lacking (Petersen and Sutton, 2006).
Clinical management of severe acute pancreatitis has improved over recent 
decades due to advances in: early radiology with CT scanning, including 
correct microbiology from fine needle aspiration (Bakker et al., 2009); 
improved supportive care (Gardner et al., 2009)(Warndorf et al., 2011); 
nutritional support; haemodialysis (Yang et al., 2010). In biliary disease, in 
particular, there is the need to balance early intervention with endoscopic 
retrograde cholangiopancreatography (ERCP) and cholecystectomy (for 
removal of further gallstones) with the clinical suitability of the patients to 
undergo these procedures. A meta-analysis of 450 patients concluded that 
early ERCP in patients with mild and predicted severe biliary pancreatitis 
(but without cholangitis), did not lead to a significant reduction in the risk of 
overall complications and mortality (Petrov et al, 2008). Definitive 
treatment by cholecystectomy should be either on the same admission or 
within two weeks of discharge on patients fit for surgery (UK working party
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for the management of acute pancreatitis, 2005). Finally surgery may be 
necessary to remove infected necrosis. While still high risk, recently this has 
been shown to have better outcomes if performed in a minimally invasive 
intervention (Raraty et ah, 2010).
There have been trials of therapeutics aimed at ameliorating severe acute 
pancreatitis. Despite initial encouraging results large studies using anti­
proteases (e.g. gabexate)(Buchler et al., 1993), anti-secretory agents (e.g. 
octreotide)(Uhl et al., 1999) and anti-inflammatory (e.g. lexipafant - a 
platelet activating factor receptor antagonist)(Johnson et al., 2001) have all 
proved disappointing. Antioxidant therapy was investigated in a well- 
conducted study which clearly showed not only no benefit from antioxidants 
but actually showed a trend toward adverse outcomes (Siriwardena et al., 
2007). Several studies have shown no benefit from prophylactic use of 
antibiotics, given in an attempt to decrease infection of necrosis (Dellinger 
et al., 2007)(Wittau et al., 2011). The failure of so many different 
approaches attests to the complexity of the disease and the need for further 
understanding of the underlying mechanisms involved.
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1.2 Experimental models of acute pancreatitis
The intracellular mechanisms involved in the development of severe acute 
pancreatitis are still unclear. In order to effect better therapy, to ameliorate 
disease progress, further work with living pancreatic tissue is vital. Human 
samples are difficult to obtain. Sampling of human pancreas during an 
episode of active pancreatitis risks worsening the disease by introducing 
infection, and is clearly unethical. Human samples are usually obtained 
during elective surgery on the pancreas (for pathologies other than 
pancreatitis), and this work is invaluable (Murphy et al., 2008). However 
even in specialist units the availability of human tissue remains limited and 
to progress understanding at a faster pace animal models are still needed. 
Animal models not only allow an understanding physiology but also allow 
testing of new potential therapies before human trials. It is a criticism of 
animal models that inter-species differences may lead to a difference in the 
mechanisms involved in pancreatitis, so that parallel experiments in animal 
and human tissue are also important.
1.2.1 Animal models of acute pancreatitis
Animal models of acute pancreatitis have been used for over a century. 
Historically most common mammalian species have been investigated and
26
although recently porcine pancreas tissue has been considered a close match 
to human pancreas tissue (Zhao et ah, 2001) it is the rodent model that is 
most prevalent. While rodents are easier to handle and cheaper to breed, it is 
in their relative ease of use in production of genetically altered animals 
(transgenic and knock-outs), that are bred to test how specific genes and 
proteins are involved in the overall pathobiological mechanism, that makes 
them an ideal animal model.
The problems with experimental models currently employed is that none are 
direct replications of human disease and the different models produce a 
spectrum of severity from mild to severe. Some models show effects on 
other organs making any assessment of MODS harder to interpret. In the 
invasive models injury from surgery may have a role in the severity of 
disease. See Table 1.2 for summary of current common experimental 
models.
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1.2.2 Secretagogue-induced models
Secretagogues are chemicals that when administered at physiological levels 
cause normal pancreatic exocrine secretion and when give in supra-maximal 
levels induce acute pancreatitis. Secretagogues used for inducing AP 
include cholecystokinin (CCK), its analogue caeruelin, carbachol 
(Chaudhuri et aL, 2005), anticholinesterase (Dressel et al., 1982), and 
scorpion venom (Pantoja et al., 1983)(Novaes et al., 1989).
Caerulein is a decapeptide with a very similar chemical structure to porcine 
cholecystokinin (CCK) and its action on gastrointestinal secretion also 
resembles CCK. It acts via CCK receptors to produce hyperstimulation of 
pancreatic acinar cells (Saluja A 1999). It was first isolated from the skin of 
the Australian frog Hyla caerulea in 1967 (Anastasi et al., 1967) and was 
used by Lampel and Kern in 1977 to induce acute pancreatitis in rats by 
giving a high dose intravenous infusion (Lampel and Kern, 1977). It was 
subsequently found to be effective at producing pancreatitis in many 
animals including mice, rats, opossums, and dogs (Niederau et al., 1985, 
Renner et al., 1986, Kahle et al., 1991).
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Caerulein has become the most extensively used in experimental models of 
pancreatitis because of several advantageous factors. It is easy to administer, 
especially if via the intra-peritoneal route (50 pg/kg/hr), or by the 
intravenous infusion (5 pg/kg/hr) and is less invasive than some surgical 
modes of induction, such as ductal infusion, and is reproducible giving 
consistent results (Niederau et al., 1985). The histological changes it 
produces are similar to those seen in human AP, and in addition it also 
causes acute lung injury. It has proved useful for assessment of potential 
therapeutic agents and for the examination of events early in the disease.
Within the first 30 minutes after administration abnormal vacuoles are 
formed, a feature of secretagogue pancreatitis. It was postulated that this 
might be due to fusion of condensing vacuoles and zymogen granules 
(Lampel and Kern, 1977), It was seen in some cells that these abnormal 
vacuoles fused with the baso-lateral membrane instead of the apical 
membrane, suggesting discharge into the interstitium of the pancreas. These 
initial changes were subsequently described in greater detail (Wantanabe et 
al., 1984; Saluja et ah, 1985; Niederau et ah, 1990). Intracellular activation 
of enzymes was shown to occur in caerulein pancreatitis in vivo, and 
together with the co-localisation of zymogen granules and lysosomes 
(Saluja et ah, 1987; Steer et ah, 1988; Willemer et ah, 1990) the inhibition
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of digestive enzyme secretion (Saluja et al 1989) and the hypothesis of
9-4-excessive Ca signalling (Ward JB et al 1995) several mechanisms of how 
caerulein induces pancreatitis have been postulated.
Caerulein and CCK produce stimulation by action on CCK receptors. In the 
pancreas of rodents CCK1 receptors, but not CCK2, are expressed on 
pancreatic acinar cells (PACs) (Wank et al., 1994). In human PACs the 
situation is reversed, with CCK2 receptors being more prevalent (Nishimori 
et al., 1999). Until recently it was controversial if these CKK receptors 
functioned the same way in humans, as in animal models. If proven this 
would have seriously harmed the validity of the hypersecretion animal 
model. This controversy was settled when work from work from our group 
categorically demonstrated that application of CCK-8 or CCK-58 at 
physiological levels caused typical intracellular changes in isolated human 
PACs (namely elevated cytosolic Ca2+, mitochondrial nicotinamide adenine 
dinucleotide phosphaste (NADPH) generation and pancreatic enzyme 
secretion) (Murphy et al., 2008). Conducting these experiments in the 
presence of either atropine or tetrodotoxin to ensure other signalling 
pathways were not involved further strengthened the evidence.
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Hyperstimulation of PACs with supra-physiological doses of CCK/caerulein
•J X
leads to [Ca ]c overload, co-localisation of lysosomes and trypsinogen, and 
abnormal secretion of activated trypsin into the pancreatic interstitium. 
Local pancreatic injury is followed by distant organ injury (esp. lung) 
(Saluja et ah, 2007)
The disadvantage of caerulein as an experimental model of pancreatitis is 
whether it can be used as a comparative model for human disease. It has 
been suggested as a demonstrating a mechanism found in rare clinical cases 
such as exposure to venom of certain scorpions or accidental ingestion of 
anti-cholinesterase insecticides (Buchler et al 1999). It is still uncertain what 
role hyperstimulation plays in human acute pancreatitis, but human 
pancreatic acinar cells have been found to have CCK receptors that respond 
in vitro to secretagogues the same way that murine pancreatic acinar cells 
do (Murphy J., et al 2008).
1.2.3 Other non-invasive experimental models
In 1975 it was reported that female mice (less than 20g) when fed with a 
choline-deficient diet with 0.5% DL-ethionine supplement (CDE diet)
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developed acute pancreatitis with massive fat necrosis. The mortality rate 
was 100% after 4 days (Lombardi et al, 1975), but severity can be altered 
with different feeding regimes. The exact mechanism is unclear, but male 
mice given oestrogen exhibited similar showed similar* changes (Rao et ah, 
1982). Larger animals have been shown to develop very mild pancreatitis 
only. Although it is the most non-invasive experimental model it is limited 
by its application only in female mice, by its toxic effects on other organs 
(mainly brain and liver) and by the length of onset (days). Larger animals 
have only shown very mild pancreatitis (Chan and Leung, 2007).
Amino-acid induced AP models include L-arginine, L-lysine (Dawra et al., 
2007)(Biczo et al., 2011) and L-ornithine (Rakonczay et al., 2008). The L- 
arginine experimental model is the most widely employed and is relatively 
non-invasive, administered usually with one or two intra-peritoneal 
injections (Dawra et al., 2007). The degree of severity depends on the dose, 
with 2.5 mg/kg leading to mild, oedematous pancreatitis and 5 mg/kg being 
enough to induce massive, necrotising pancreatitis in rats (Mizunuma et al., 
1984)(Kishino et al., 1984), rabbits and mice (Zhao et al., 2004)(Darwa et 
al., 2007). L-arginine also has little effect on other organs, so that its 
specificity, dose-dependent severity and ease of use make it a commonly 
used experimental model. How L-arginine produces its effects is unclear,
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but experimental evidence suggests protein synthesis inhibition as the most 
likely mechanism: specifically suppression of ornithine decarboxylase, 
which ultimately leads to a reduction in nucleic acid and protein synthesis. 
As the pancreas is highly metabolic it is vulnerable to this toxicity (Chan 
and Leung, 2007). Its disadvantage is its lack of relevance to clinical 
practice.
Alcohol abuse is an important aetiology in human APs, however the 
mechanism is unclear. Animal experiments administering ethanol alone 
(either i.v. or orogastric) have failed to show evidence of AP (Letko et al., 
1991), unless simultaneously given with a physiological does of another 
agent such as CCK and secretin (Siech et al, 1991). When ethanol is given 
with caerulein (Foitzik et al., 1994) or bile acid (Andrzejewska et al., 1998) 
the AP seen in animal models more severe, suggesting that ethanol is a 
potentiator of AP as opposed to a primary cause. This would seem to 
correlate with human AP related to alcohol where only a small number of 
patients abusing alcohol actually develop AP (compared with, say, liver 
disease).
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1.2.4 Invasive experimental models
Several invasive animal experimental models of AP exist and all require 
surgical intervention, needing specialist expertise and resources. The models 
described are grouped as: vascular/ischaemic models; closed duodenal loop; 
duct ligation models; duct perfusion models.
Vascular impedance can cause pancreatitis and there are several ways to 
achieve this, though the relevance to human disease is doubtful. 
Hypovolaemic shock by sudden loss of 30-35% blood volume can cause 
pancreatitis in dogs (Brasilia et al., 1987) and has a clinical counterpart in 
human disease with AP seen after hypotension in surgery (esp. cardiac 
bypass). Injection of microspheres in rodents causes AP (Pfeffer et al., 
1962)(Reddha et al., 1990). Others studies have ligated the arteries 
supplying the pancreas (superior pancreatico-duodenal artery/ superior 
mesenteric artery) to demonstrate experimental AP (Spormann et al., 
1989)(Waldner 1992). Alternatively venous outflow can be impeded by 
occlusion of the splenic/gastro-duodenal veins, which can lead to SAP 
(Sjovall et al., 1988). Overall vascular models are not widely employed. 
They often have traumatic effects on other organs not directly from AP but 
from systemic injury instigated by surgery or rapid blood loss (Chang and
36
Leung et aL, 2007). There is also limited evidence human AP is caused by 
vascular impedance.
The closed duodenal loop model was originally described in 1910 (Seidel 
1910) but was investigated in more detail half a century later in 1957 
(Pfeffer et ah, 1957). This model requires extensive surgery: the duodenum 
is divided distally and proximally to the insertion of the pancreatic duct PD, 
creating a blind loop, with the bowel being rejoined in a gastro-jejunostomy 
(Chang and Leung, 2007). The model investigates if duodenal content reflux 
into the PD causes AP. The model has been modified slightly over the years 
(Sugimoto et al., 2004). The model has lent weight to bile involvement in 
SAP (Chetty et al., 1980). However there is no evidence this is how human 
AP occurs, and, taken with the complexity of the surgery required, means 
this is not a widely used experimental model.
1.2.5 Duct obstruction-induced model
The duct obstruction experimental model mimics human gallstone 
pancreatitis and, although it requires surgery and is invasive, it is relatively
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straight forward technically, requiring only ligation of the pancreatic duct 
(PD) with vertical cannulation or balloon tip catheter in the rat (Chan and 
Leung, 2007) The opossum is an interesting model as it has also has a 
common biliopancreatic duct (CBPD)(Lerch et ah, 1992). The opossum 
model produces a SAP with over 50% necrosis, compared to approximately 
10% in the rat. (Kaiser et al., 1995). It is postulated that bile reflux damages 
pancreatic acinar cells, but it is also suspected that a build up of pressure in 
the PD from pancreatic secretions also has a role as it is observed that the 
longer the obstruction is applied the more severe the AP. Removal of the 
obstruction after 24 hours in rodents invariably results in complete 
resolution (Azima et al., 1996), but a more recent model in mice showed 
100% mortality after four days of PD ligation (Samuel et al., 2010), again 
suggesting a need for build-up of pancreatic secretion and pressure. Duct 
obstruction with concurrent additional stimulus (e.g. secretagogue) 
invariably worsens AP compared to duct obstruction alone (Yoshinaga et 
al., 2000)(Chang and Leung, 2007). This model is strengthened by its 
clinical relevance.
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1.2.6 Duct perfusion-induced model
Cannulation and perfusion of the pancreatic duct with chemicals linked to 
AP (usually bile salts but also ethanol metabolites) will elicit AP in animal 
models, and has been extensively used as a proxy for human disease. The 
commonly used bile salts are: sodium taurocholate (Na-TC), 
taurolithocholic acid 3-sulphate (TLC-S) (Perides et ah, 2010a&b), sodium 
glycodeoxycholic acid (Na-GDC) (Schimdt et al., 1992), and 
taurodeoxycholate (Na-TDC) (Jin et al., 2008 and Jin et ah, 2011). This 
model requires surgical intervention, and as large animals show AP 
changes, but not MODS, it is the rodent model that predominates, as it 
shows both changes. Being a smaller animal model the technique of PD 
cannulation and perfusion can be technically demanding. The infusion 
pressure must be carefully controlled (usually with a pump) as a raised PD 
duct pressure with saline can cause mild AP by itself (Lichtenstein et al., 
2000).
Na-TC in rodents is the most widely used PD bile salt-infusion model and 
induces oedema, haemorrhage and necrosis depending on the dose infused 
(usually 3-6%) (Chan and Leung, 2007). It has also been shown to cause 
MODS, with injury especially in the lungs (Chen et ah, 2008) as is seen in
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human disease. It can be combined with other models, including LPS 
(simulating septic shock)(Segersvard et al., 2004); e.coli (representing an 
infective component in human disease) (Zhou et ah, 2008) and with trypsin 
(Yamano et al., 1998) generally resulting in more severe disease. More 
recently a non-lethal murine model has been described (Laukkarinen et al., 
2007 and Perides et al., 2010b) generally affecting the head of the pancreas 
only. Thus a spectrum of severity now exists in Na-TC rodent models.
The so-called Boston model (Schimdt et al., 1992) combined caerulein with 
PD infusion of Na-GDC leading to SAP with MODS. The pattern of 
disease, onset of symptoms over 24 hours and a mortality of about 20%, 
mirrors human disease.
TLC-S in used extensively in in vitro work with isolated pancreatic acinar 
cells (PACs), where it has been shown to be taken up by G protein-coupled 
bile acid receptor-1 (Gpbarl). Hyperstimulation of isolated PACs with 
TLC-S leads to increased [Ca2+]i which in turn injures the mitochondria and, 
depending on level of damage, to either apoptosis or necrotic pathways. 
This been confirmed in animal models using genetic knock-out (KO) mice 
Gpbarl -/-. These animals were protected against TLC-S induced AP, with
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no change seen in either in vivo (PD infusion models or in vitro models 
(isolated PACs) compared with controls (Perides et al., 2010a).
Despite being technically demanding the PD-infusion model of AP has 
many parallels to human gallstone AP. It is a current popular experimental 
model, especially in rodents.
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1.3 Apoptosis and necrosis in acute pancreatitis
Events that regulate the severity of acute pancreatitis are unknown and may 
be multi-factorial; for instance the induction of an inflammatory reaction 
with recruitment of inflammatory cells, such as neutrophils, may be 
responsible for local damage. How the pancreatic acinar cells (PACs) 
themselves react to damage early in the course of the disease is likely to be 
important to the severity of the outcome. Several studies over the last 15 
years have shown that ‘programmed’ cell death by apoptosis appeal’s to be 
protective whilst ‘uncontrolled’ death by necrosis is associated with more 
severe disease. Some experimental animal models have sought to induce 
apoptosis in PACs prior to using an established model of experimental 
pancreatitis (as listed in the previous section) and have shown a milder 
outcome (Bhatia et ah, 1998). However the mechanisms involved in PACs 
apoptosis are currently uncertain, though identification of mechanisms that 
might ‘switch ’ necrosis to apoptosis could improve outcome (Pandol et ah, 
2007). Until recently apoptosis was seen as an organised and complex cell 
death process, with necrosis as an uncontrolled process, but this view of 
necrosis is slowly changing (Golstein and Kroemer, 2007).
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1.3.1 Morphology in apoptosis and necrosis
Apoptosis was first described in 1972 for a morphologically distinct form of 
cell death (Kerr et ah, 1972). The typical morphological features of 
apoptosis are cytoplasmic and nuclear shrinkage, chromatin margination and 
fragmentation, and breakdown of the cell to several residual ‘apoptotic 
bodies’ (Majno and Joris, 1995)(Bhatia 2004). These bodies are recognised 
by macrophages, through externally located phosphatidylserine moieties 
(Criddle et al., 2007a), and removed from the tissues with minimal 
inflammation (Pandol et al., 2007).
Necrosis is triggered by pathological, extrinsic factors (e.g. toxic or 
traumatic insults) and in the context of AP this includes secretagogue 
hyperstimulation (CCK, Caerulein), bile salts (Vornina et ah, 2002), ethanol 
metabolites (esp. FAEE) (Criddle et al., 2006), Ca2+ overload (Ward et al., 
1995)(Kruger et al. 2000)(Petersen and Sutton, 2005)(Criddle et al., 
2007a+b), excessive reactive oxygen species (ROS) and depletion of 
Adenosine Trisphosphate (ATP) through loss of mitochondrial membrane 
potential (ATTn) (Criddle et al., 2006). Necrosis is characterised by 
mitochondrial swelling and dysfunction, followed by rapid swelling of the 
cell and nuclear pykinosis due to loss of cell membrane integrity. The
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resultant release of lysosomal and granular contents into local tissues causes 
inflammation (Majno and Joris, 1995)(Barros et al., 2001)(Bhatia 
2004)(Gukovsky et al., 2011).
1.3.2 Caspase cascade
Apoptosis is a highly co-ordinated process and is regulated by a family of 
aspartate-specific cysteine proteases, called caspases. Caspases are initially 
stored in an inactive form (pro-caspase) and require activation. The peptide 
cleavage required to convert pro-caspases to active caspases is specific and 
occurs at aspartate residues, meaning that other caspases are responsible and 
leading to the theory of a caspase cascade. As a further control cells also 
synthesise a range of inhibitor proteins (e.g. ‘inhibitor of apoptosis proteins’ 
or TAP) (Slee et al., 1999)(Mace et al., 2010). Caspases are divided into two 
active groups: ‘effectors/executioners’ (inc. caspases 3, 6 and 7) which 
actively disassemble the cell structures; and ‘initiators/activators’ (inc. 
caspases 2, 8 and 9) which trigger cleavage and activation of the 
‘effectors/executioners’ (Slee et al., 1999)(Criddle et al., 2007a)(Pandol et 
al, 2007).
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Initiator/activator caspases are activated either by an extrinsic pathway or an 
intrinsic pathway. In the extrinsic pathway ’death receptors’ (e.g. TNF- 
Receptor family such as CD95/FasR/APO-l) situated in the cell membrane 
are activated and, via ‘adaptor molecules’ (e.g. FADD), recruit membrane- 
bound caspases (esp. caspase-2 and caspase-8). These caspases are then 
activated and initiate the caspase cascade. In the intrinsic pathway the 
mitochondria is central to the process, with mitochondrial membrane 
permeabilization (MMP) a universal trigger and ‘point of no return5 in cell 
death pathways (Gukovsky et ah, 2011). The stimulating group in the 
intrinsic pathway is diverse, including radiation, heat stress and cytotoxic 
drugs that ultimately results in the protein cytochrome c release from the 
mitochondria. Once in the cytosol cytochrome c combines and interacts with 
‘apoptotic peptidase activating factor 1’ (APAF-1) and procaspase-9 
forming an ‘apoptosome with activation of caspase-9. Caspases-9 activates 
effector caspases, especially caspase-3 and caspase-7. Caspase-3 appears to 
have greater importance as studies of loss of caspase-3 show that other 
‘downstream’ caspases (i.e. caspase-2 and caspase-6) are not activated (Slee 
et al., 1999). Any process leading to cytochrome c release can activate the 
intrinsic pathway, so that the intrinsic and extrinsic pathways can be 
connected. Figure 1.1 shows a simplified representation of the intrinsic and 
extrinsic pathways.
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There may be crossover between these pathways, as Caspase-8, although 
activated via the extrinsic pathway, can also engage the intrinsic 
(mitochondrial) pathways by activation of BID. BID in turn affects MMP 
and leads to release of cytochrome c (Slee et ah, 1999)(Gukovsky et al., 
2011).
1.3.3 BcI-2 family proteins
Other key molecules regulating cell death are proteins of the Bcl-2 (B-cell 
lymphoma 2) family (Kroemer et al., 2007). The name derives from Bcl-2 
first being described in follicular lymphoma. The Bcl-2 family are 
subdivided into 3 groups based on their Bcl-2 homology (BH) domains and 
on whether they are pro-survival (anti-apoptotic) or pro-apoptotic (Kroemer 
et al., 2007)(Chipuk et al., 2008)(Gukovsky 2011). The pro-survival 
members (Bcl-2 and Bcl-xL) contain 4 domains (BH1-4), the pro-apoptotic 
members (Bax and Bak) contain 3 domains (BH1-3) and, finally, the BH3 
members, also considered pro-apoptotic, contain one domain (e.g. BAD, 
BID or Puma).
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Bak (Bcl-2 homologous antagonist/killer) and Bax (Bcl-2 associated x 
protein) are described as ‘pro-apoptotic’ and are involved in the formation 
of the mitochondrial outer membrane pore (MOMP), through which 
cytochrome c is released. Bak is predominantly localised to mitochondria, 
whereas Bax is found in the cytosol. Activated Bax promotes apoptosis in 
two ways. First by inserting into the outer mitochondrial membrane (OMM) 
with Bak to form the MOMP. Second by inducing opening of the separate 
mitochondrial permeability transition pore (MPTP), which also leads to 
release of cytochrome c (Galluzzi et al., 2009)(Gukovsky et ah, 2011).
Pro-survival (or anti-apoptotic) Bcl-2 and Bcl-xL act by inhibiting Bak and 
Bax, stopping the formation of the MOMP, or by inhibition of cytochrome c 
(Bhatia, 2004)(Gukovsky et al., 2011). However this may not be entirely 
straight forward as more recently it also appears that Bcl-2 and Bcl-xL have 
a role in regulating necrosis, through effects on mitochondrial membrane 
potential (AvFm); namely the difference in their effects on AvFm versus their 
effects on cytochrome c inhibition (Sung KF et al., 2009). In experimental 
in vitro models of CCK-induced changes it was demonstrated that inhibiting 
Bcl-2 and Bcl-xL increases loss of ATm and facilitates necrosis, whilst also
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inhibiting CCK-induced caspase-3 activation and apoptosis. The net result, 
surprisingly, being an increase in necrosis and not apoptosis as expected.
The other pro-apoptotic BH3 proteins support the role of Bak/Bax either by 
interacting directly and promoting MOMP formation (e.g. BID), or by 
interfering with the inhibitory actions of Bcl-2/Bcl-xL (e.g. BAD).
1.3.4 Role of the mitochondria in pancreatic acinar cell death
Mitochondria have long been known to be the main organelle supplying 
energy to the cell in the form of ATP. In the last 15 years it has become 
clear that they play a central role in cell death as well (Kroemer et ah, 
2007), determining whether apoptotic pathways or necrotic pathways are 
followed. They are central to tire activation of the intrinsic pathway of 
apoptosis, whereas any inability to supply ATP may lead cells to a necrotic 
pathway. The structure of mitochondria, with different compartments, is 
important to their function. These compartments are the: outer membrane, 
inter-membrane space, inner membrane and the cristae and matrix 
(Hermann and Neupert, 2000) (see figure 1.2). The outer membrane
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contains channel-forming proteins called porins, which allow molecules less 
than 5000 Daltons to diffuse across the membrane; for larger molecules 
there are active transport mechanisms. Cytochrome c is contained in the 
inter-membrane space and disruption of the outer membrane will lead to its 
release and activation of the intrinsic pathway. The inner membrane 
encloses the matrix, which is the site of ATP production. The inner 
membrane maintains a mitochondrial membrane potential (ATTn) of 150- 
180 mV across the inner mitochondrial membrane by actively pumping 
protons into the inter-membrane space (Mukherjee et al., 2008).
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Outer
mitochondrial
Inner
mitochondrial
Figure 1.2: Representative diagram showing basic structure 
of mitochondrion. In particular demonstrating the outer 
mitochondrial membrane (OMM), the inter-membrane space 
and the inner mitochondrial membrane (IMM). The matrix is 
further demonstrated as contained within the IMM.
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1.3.5 Role of Calcium signalling and mitochondrial function
The AThn is important for many of the functions of mitochondria, and one 
of these is concentration of Ca2+ within the matrix (where Ca2+ has a role in 
activating Kreb’s cycle enzymes). Loss of AThn (second to an abnormal rise 
in [Ca2+]i triggered by toxins (further described in Ca2+ signalling section)) 
(Petersen and Sutton, 2005)(Criddle et ah, 2007a)(Mukherjee et ah, 2008), 
leads to loss of ATP production and ultimately death by necrosis (see figure 
1.3). Experimental evidence supporting the role of toxic Ca2+ signalling in 
loss of mitochondrion function is found by either excluding Ca , following 
toxic signals, with a Ca2+ chelator (Voronina et ah, 2002)(Criddle et ah, 
2004), or by providing supplementary in vitro intracellular ATP after a toxic 
rise in [Ca2+]i (Criddle et ah, 2006), both of which allow survival of the 
pancreatic acinar cell (PACs).
Mitochondria have an important role in maintaining PACs Ca2+ 
homeostasis, which is critical for PACs function (Park et ah, 
2001)(Voronina et ah, 2002). Mitochondria are important in buffering the 
Ca2+ signals released in the apical section of the cells from the rest of the 
cell and provide ATP for energy dependent termination of Ca2+ signals by 
uptake by Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) and plasma
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Stress signals
i
Apoptosis
ATP
depletion
X
Necrosis
2+
Figure 1.3: Mitochondria as central to cell death pathways. Toxic Ca levels and
other stresses, lead to cytochrome c release from the inner mitochondrial
2+
membrane, activating caspases (and inducing further Ca release via IP3Rs). 
These events may be controlled by Bax/Bak channels (shown in blue). Caspase 
activation has a protective role in pancreatitis, but requires adequate supply of 
ATP. Marked loss of mitochondrial membrane potential, notably with induction 
of the MPTP (shown in red), inhibits ATP production, which in turn inhibits 
apoptosis and leads to necrosis. (From Mukherjee et al., 2008)
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membrane Ca2+ ATPase (PMCA) activity (see section on Ca2+ signalling) 
(Petersen 2005 & Petersen et al., 2006).
1.3.6 Mitochondrial membrane permeabilisation
Mitochondria regulate apoptosis/necrosis in two ways. Firstly by 
mitochondrial membrane permeabilisation (MMP), which is a key ‘point of 
no return’ in apoptosis/necrosis (Galluzzi et al., 2009)(Gukovsky et al>5 
2011) and is brought about by activation of two separate membrane 
systems: the mitochondrial permeability transition pore (MPTP) and the 
mitochondrial outer membrane pore (MOMP), both of which lead to release 
of cytochrome c. Secondly by loss of production of ATP which ultimately 
leads to death by necrosis.
The MPTP is thought to determine cell fate from injury and is linked to the 
degree of loss of AThn, with a potentially small, recoverable loss of AT'm 
leading to apoptosis and an unrecoverable loss of ATTn leading to loss of 
ATP production and death by necrosis (Mukherjee et al., 2008). MPTP 
opening across the inner mitochondrial membrane (IMM) leads to loss of 
ATTn and ATP production. It is formed from at least 3 components: Voltage
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dependent anion channel (VDAC) in the outer membrane, adenine 
nucleotide translocase (ANT) in the inner membrane and Cyclophilin-D 
(CyP-D) within the matrix (see figure 1.4a below) (Kroemer et al., 
2007)(Mukherjee et al., 2008). CyP-D is thought to be the predominant 
regulator and high concentrations of Ca induce conformational changes 
that lead to these proteins forming the MPTP (Kroemer et al., 2007) with 
subsequent release of cytochrome c.
Figure 1.4. Mitochondrial membrane permeability. (A) The MPTP is a large
nonselective channel the components of which include Cyp D, VDAC, and ANT.
2+
MPTP opening is stimulated by Ca and ROS and leads to release of cytochrome 
c. (B) The MOMP channel is formed by the pro-apoptotic Bcl-2 proteins Bax and 
Bak. There is evidence that the prosurvival Bcl-xL protein may inhibit both MPTP 
and MOMP.(Abbreviations: Cyp D, cyclophilin D; VDAC, voltage-dependent 
anion channel; ANT, adenine nucleotide translocase; ROS, reactive oxygen species; 
Cyt c, cytochrome c; CL, cardiolipin. (figure from Gukovsky et al., 2011)).
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Overload of signals (esp. from toxic levels of [Ca2+]j) leads to a sustained 
opening of the MPTP, with uncontrolled entry of solutes and water with 
subsequent leakage and swelling of the mitochondria. This leads to a loss of 
ATP and ultimately cell necrosis (review figure 1.4). Studies inhibiting 
MPTP function (with bongkrekic acid) have shown a reduction in apoptosis 
(Gerasimenko et al., 2002), which supports its role in the intrinsic pathway. 
However there must more than one way to induce the intrinsic pathway as 
cyclophilin D (CyP-D) knock-out transgenic mice show no protection from 
a range of apoptosis inducing stimuli (Nakagawa et al., 2005)(Mukherjee et 
al., 2008). Indeed further collaborative work from our group in Liverpool 
has shown that CyP-D ablation greatly reduced necrosis in 3 dissimilar 
models of pancreatitis proving further evidence that the MPTP is also 
involved in necrosis, and perhaps more so than it is involved in apoptosis 
(Gukovsky et al., 2011). These results suggest that apoptosis may actually 
be mediated more by another MMP pore: the mitochondrial outer membrane 
pore (MOMP).
The MOMP are large channels formed by the pro-apoptotic Bak and Bax 
proteins, though the full mechanism of action is currently unknown. When 
activated they release cytochrome c and activation of the intrinsic pathway 
(see figure 1.4b). There may be overlap between the MPTP and the MOMP.
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1.3.7 Evidence that apoptosis is protective in acute pancreatitis
Analysis of experimental models of AP show that severe acute pancreatitis 
(e.g. that seen in opossum PD ligation, or by caerulein hyperstimulation in 
the mouse) is associated more with necrosis, and that milder experimental 
models are seen to have much higher relative levels of apoptosis (Kaiser et 
ah, 1995)(Bhatia, 2004). Looking specifically at the hyperstimulation 
model, it has been shown by one group that caerulein can induce apoptosis 
by stimulating platelet-activating factor (PAF), which in turn regulates 
apoptosis (Sandoval et ah, 1996). Subsequently CCK has been shown to 
stimulate death-signalling pathways in rat PACs by activating caspases, 
releasing cytochrome c and by mitochondrial depolarisation (Gukovskaya et 
al., 2002). Caspases also help inhibit necrosis and intra-PACs trypsin 
activation. One group used a plant nitrile extract called crambene (1-Cyano- 
2-hydroxy-3-butene (CHB)), which induces apoptosis (Bhatia et al. 1998). 
When caerulein hyperstimulation was administered to mice pre-exposed to 
crambene, they were protected against AP. However, as the exact 
mechanism of crambene action is unclear, caution should be shown before 
attributing all of crambene’s protective effects as simply pro-apoptotic.
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Crambene could be affecting pancreatitis severity through actions other than 
on apoptosis. Crambene may affect gap junction communication (GJC). 
Mice deficient in a gene coding for GJC (Connexin 32) are not protected 
from caerulein hyperstimulation AP despite the administration of crambene 
(Frossard et ah, 2003).
1.4 Pancreatic acinar cells and calcium signalling 
1.4.1 Pancreatic exocrine function
Everyday the human pancreas secrets about 1.5 litres of fluid, rich in 
digestive enzymes (called zymogens), bicarbonate and water. The 
bicarbonate and water are predominantly produced by the cells of the 
pancreatic duct (PD). The relatively high pH helps to neutralise the acidic 
chyme that exits from the stomach into the duodenum, providing an optimal 
pH for digestive enzymes to function. The pancreatic acinar cells (PACs) 
are grouped together in clusters called acini {singular: acinus), and produce 
and secrete zymogens into the lumen of the acini. Zymogens are capable of 
breaking down the vast majority of proteins (e.g. trypsin, chymotrypsin), 
fats and phospholipids (e.g. lipase, phospholipase) and carbohydrates (e.g.
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amylase, carboxypeptidase) that are ingested. In order to protect the PACs 
from self-digestion, these zymogens are stored in an inactive state (pro­
zymogens) within PACs, inside localised secretory granules (also called 
zymogen granules) (Raraty et ah, 2000). These secretory granules are 
clustered in the apex of the PACs, adjacent to the acini lumen ready for 
secretion. Trypsin is thought to be the first enzyme activated and 
subsequently leads to activation of the others zymogens as part of an 
enzyme activation cascade. Under physiological conditions this activation 
occurs in the duodenum where trypsinogen is converted to active trypsin by 
the enzyme enteropeptidase (formerly called enterokinase). Enteropeptidase 
is produced by cells lining the duodenum. Premature activation of 
trypsinogen in the apex of PACs is now widely acknowledged as the key 
event in the autodigestive process. This premature activation has been 
shown to be triggered by PD hypertension, bile salts, ethanol, ischaemia, 
hypercalcaemia, hyperlipidaemia, drugs and toxins (Sutton et al., 2003). 
Premature activation within and around acinar cells leads to cytoskeleton 
disruption, co-localisation of zymogens and lysosomes (Gorelick and 
Matovcik, 1995), vacuole formation and pro-inflammatory cytokine 
expression, ultimately resulting in acute pancreatitis (Ward et al., 
1996)(Sutton et al., 2003). The exact process of the mechanisms leading to 
activation are still unclear, but work from our group and others have shown
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that toxic Ca2+ signalling plays a critical role (Ward et al., 1995)(Raraty et 
al., 2000)(Sutton et ah, 2003)(Criddle et al., 2007b). PACs have some 
protection against low-level inadvertent premature activation of trypsinogen 
to trypsin, through inhibitory mechanisms such as pancreatic secretory 
trypsin inhibitor (PSTI) (Nathan et al., 2005). The importance of 
trypsinogen activation has been further clarified by studies on families with 
hereditary pancreatitis, which is caused by mutations of the cationic 
trypsinogen (PRSS1) gene. The resultant abnormal trypsinogen is thought to 
cause pancreatitis by being more likely to undergo auto-activation, and by 
being more resistant to normal inhibition from PSTI (Whitcomb et al., 1996) 
(Pfutzer et al., 2000)(Howes et al., 2005)(Crocock et al., 2010). Although 
currently demonstrated to be the most important prematurely activated 
enzyme, trypsinogen may not be alone, as there is evidence to support 
premature activation of other enzymes such as cathepsin B and granular 
elastase (Halangk et al., 2000)(Sutton et al., 2003).
Secretion from PACs is controlled by both neural and hormonal pathways 
(Gorelick and Jamieson, 1994). Neural control is via cholinergic and 
peptidergic pathways, with messengers including acetylcholine (ACh) 
vasoactive intestinal peptide (VIP) and gastrin-releasing peptide (GRP) 
(Holst 1993). Hormonal control is via cholecystokinin (CCK) and secretin.
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CCK is released by duodenual I cells (Chey et al., 1993) and causes 
secretion of zymogens from PACs. Secretin acts to stimulate water and 
bicarbonate secretion from pancreatic ductal cells.
Under physiological conditions vagal stimulation is recognised in an early 
‘cephalic phase5 of PACs secretion. This is followed by a ‘gastric phase5 in 
which stretch receptors in the stomach activate a vagally-controlled reflex. 
In the last ‘intestinal phase5 both neural and hormonal pathways lead to 
pancreatic exocrine secretion. Secretion is inhibited by somatostatin and its 
analogues.
1.4.2 The pancreatic acinar cell
Pancreatic acinar cells (PACs) have several structural arrangements that are 
particular to their role as a secretory cell. They are bound together in acinar 
clusters by tight junctions. PACs show marked structural polarity with 
secretory granules (containing zymogens) clustered at the apical pole, on the 
acinar lumen side. The endoplasmic reticulum (ER) is extensive, reflecting
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the role of PACs in the manufacture of zymogens. The ER is predominantly 
found in the basolateral region of the cell, but has projections into the apical 
region, where secretory granules bud off from the ER (Park et aL, 2000). 
The nucleus is found in the baso-lateral region. The PACs are also noted for 
particular groupings of mitochondria. In particular surrounding the nucleus 
and, more notably, forming a buffer zone between the secretory granules 
and the rest of the cell (peri-granular mitochondrial belt) (Tinel et al., 1999), 
where they have been show to play an important role in reducing toxic Ca2+ 
signals (Criddle et al., 2007b). The golgi apparatus is found between the ER 
and the peri-granular mitochondrial belt. Isolated PACs used in 
experimental work retain this particular structural arrangement (see figure 
1.5).
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Figure 1.5: EM and light microscopic images of FACs. A. Shows an 
electronmicroscopic image of a pancreatic acinar cell. Note the clustering of 
secretory granules at the apical pole and the extensive basol-lateral endoplasmic 
reticulum. Also indicated are golgi apparatus and condensing vacuoles. (From 
Bloom and Fawcett, 1975). B Shows a typical view of isolated murine pancreatic 
acinar cells when viewed with a light microscope. In this image a doublet is 
shown. Note the secretory granules again clustered at the apical poles. (Taken 
by myself, using a two-photon light microscope).
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1.4.3 Normal Ca signalling in pancreatic acinar cells
Ca2+ is a universal second messenger found in many diverse cell types. In 
PACs Ca2+ signals are triggered by neurotransmitters (e.g, ACh) and 
hormones (esp. CCK). As detailed in the previous section, these Ca2+ signals 
are linked to secretion of the zymogens from secretory granules in the apical 
part of the PACs. This process, where a stimulant applied to a cell leads to a 
chain of events resulting in secretion, is called ‘stimulus-secretion coupling’ 
and was first described five decades ago (Douglas et al., 1968). Under 
normal conditions there exists a Ca2+ concentration gradient within the 
PACs, with a cytosolic concentration ([Ca]i) in the range 10“7 M, compared 
to a range of 10'4 within the ER (intra-eellular stores) and 10"3 M in the 
extra-cellular fluid (Sutton et al., 2003)(Raraty et al., 2005). This 
concentration gradient is maintained between the cytosol and the extra­
cellular fluid by the Mg2+ dependent plasma membrane Ca2+ ATPase pumps 
(PMCA), and between the cytosol and the ER by sarco/endoplasmic 
reticulum Ca2+ ATPase pumps (SERCA). This low concentration of [Ca2+]j 
allows small, transient, oscillatory rises in Ca2+ to be used as a signalling 
messenger (Sutton et al., 2003)(Raraty et al., 2005).
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• 4 0 \Following ACh/CCK stimulation transient oscillations of [Ca ]i are actually 
first detected in the apical pole in the same area as the secretory granules 
(Ashby et ah, 2002)(Criddle et ah, 2007b). These spikes of [Ca2+]i then 
spread towards the baso-lateral region of the ER, but are limited by uptake 
by the peri-granular mitochondria which act as a buffer taking up Ca2+ 
(Tinel et ah, 1999)(Park et ah, 2001). The SERCA and PMCA pumps then 
restore [Ca2+]j by transporting Ca2+ into the ER and out of the cell 
respectively (Petersen, 2005). Even without signalling there is a low-level 
continuous leak of Ca2+ from the ER, which the SERCA pumps counter. See 
figure 1.6.
Each transient rise in [Ca2+]i is associated with an increase in mitochondrial 
NADH production and ATP production (Voronina et ah, 2002), thus 
supporting the role of cytosolic Ca2+ signals as part of physiological energy- 
dependent PACs secretion (Criddle et ah, 2007b). The positioning of 
mitochondria as a peri-granular buffer, and also in close proximity to the 
ER, indicates these are areas of high metabolic demand (Park et ah, 2001), 
with Ca2+ uptake by the mitochondria necessary for Krebs cycle activity and 
ATP production.
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5
Secretion
SOC PMCA
Figure 1.6: Normal Ca signalling in pancreatic acinar cells. Diagram 
shows a representative PAC, with zymogen granules (black circles) in 
apex, surrounded by peri-granular mitochondrial belt (green) and an 
extensive endoplasmic reticulum (blue) 1) CCK binds to specific CCK^ 
receptors, which leads to release of second messengers cADPR and 
NAADP. 2) ACh binds to muscarinic receptors, which leads to release of 
IPr 3) cADPR and NAADP bind to RyR in the ER membrane and IP3 
binds to IP Rs in the ER membrane and in ZG membranes. 4) Thee '
2+
combined action so of 3) leads to rapid rise in apical Ca levels. This
2+
wave spreads to the perigranular mitochondria, where some Ca is taken
up to activate ATP production. 5) ATP drives secretion of ZG from the
2+
apex of the PACs. 6) Ca is actively taken up by SERCA, pumps in the
ER membrane. Ca levels are returned to baseline by 7) actively pumping 
2+ 2+ 
of Ca out of the cell by plasma membrane Ca activated pump (PMCA)
2+
and 8) diffusion of Ca through Store-operated channels (SOC).
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As described above, following ACh/CCK stimulation, transient Ca 
oscillations are first seen in the apical pole of the PACs. However neuro- 
hormonal receptors are located in the baso-lateral membranes of the PACs, 
so secondary messengers are required to transmit the neuro-hormonal 
signals from the baso-lateral membrane to the apex. These secondary 
messengers have been identified as inositol trisphosphate (IP3), cyclic 
adenosine dinucleotide phosphate ribose (cADPR) and nicotinic acid 
adenine dinucleotide phosphate (NAADP) (Cancela et al., 2002)(Yamasaki 
et ah, 2005). These secondary messengers cause Ca2+ release from ER stores 
by interaction with receptors in the apical portion of the ER, adjacent to the 
secretory granules. These receptors function as Ca2+ channels, and when 
activated release Ca2+ into the apical portion of the PACs. The receptors are 
the IP3 receptor (IP3R) and the ryanodine receptor (RyR) (Petersen, 2005). 
ACh stimulation acts predominantly via IP3, with actions on the IP3R 
(Petersen, 2005)(Raraty et al., 2005), whereas CCK stimulation acts via 
NAADP and cADPR which are thought to act on RyR (Yamasaki et al., 
2005)(Raraty et al., 2005)(Criddle et al., 2007b) though it is possible 
NAADP may have its own receptor as well. Whichever receptor is activated 
first is then capable of activating the other receptors in a process termed 
‘calcium-induced calcium release’ (see figure 1.7). The consequence of 
these two separate second messenger pathways is that they converge to
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induce a local, rapid magnification of Ca2+ release. This release ends when 
Ca2+ levels peak and then show a negative feedback inhibitory action on 
these ER Ca2+ release channels (Raraty et al, 2005). In combination with the 
previously described perigranular mitochondria buffering effect, ER uptake 
and PMCA extrusion from the cell, local [Ca2+]j levels return to normal, 
resting levels (refer back to figure 1.6). When this buffering ability is 
overwhelmed, toxic Ca signalling results.
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1.4.4 Toxic Ca signalling in pancreatic acinar cells
When PACs are stimulated with very high doses of neuro-hormonal 
transmitters (e.g. Ach or CCK) instead of the localised, transient rises in 
[Ca2+]i seen in normal signalling, a dramatic, sustained, global rise in [Ca2+]i 
occurs (Cancela et ah, 2002)(Ward et ah, 1999)(Raraty et ah, 
2005)(Petersen, 2005)(Criddle et al, 2007b). After the initial global rise in 
[Ca ]i there is a fall to an elevated baseline, but not to normal resting 
cytosolic Ca2+ levels. This disruption in cell signalling is thought to lead to 
inappropriate enzyme activation, vacuole formation, cytoskeletal damage, 
mitochondrial depolarisation, loss of plasma membrane integrity, cytokine 
expression, culminating in the events of acute pancreatitis (Raraty et ah, 
2005)(Sutton et ah, 2003). Experiments showing the critical role of 
sustained [Ca2+]i include those loading PACs with BAPTA (a Ca2+ 
chelator). BAPTA loading prevents global Ca2+ rises and PACs show no 
signs of premature enzyme activation (Raraty et ah, 2000). Other 
compelling evidence for the role of Ca2+ comes from hyperstimulation 
experiments in PACs in the absence of Ca2+ in the extra-cellular fluid. No 
evidence of Ca2+ spikes or PACs damage is shown, suggesting that 
sustained Ca2+ entry into the cell must play an important role in toxic Ca2+ 
signalling (Raraty et ah, 2000)(Voronina et ah, 2002)(Criddle et ah, 2007b).
70
Further evidence is seen in experiments involving the enzyme 
phosphatidylinositol 3-kinase (PI3K), which has an inhibitory action on 
SERCA. Pharmacological inhibition or knockout of the PI3K gene leads to 
protective effects in experimental pancreatitis (Singh et al, 2001)(Lupia et 
al, 2004)(Criddle et al., 2007b).
This toxic response to hyperstimulation is also seen with other, more 
clinically relevant, stimulants in experiments on isolated PACs. These 
include bile salts and non-oxidative ethanol metabolites (in the form of fatty 
acid ethyl esters - FAEEs) (Voronina et al, 2002a)(Criddle et al., 2006) and 
in pancreatic duct obstruction experiments (Mooren et al., 2003). It has been 
demonstrated that bile acids and fatty ethyl esters induce a sustained 
increase in [Ca2+]i in part through action on IP3R calcium release. This 
effect can be blocked by caffeine (Voronina et al., 2002a)(Criddle et al., 
2006). As well as IP3R action FAEEs accumulate in mitochondria, causing 
damage and reduction in ATP necessary to drive SERCA and PCMA pumps 
(Criddle et al., 2006). Likewise inhibition of RyR both in vitro and in vivo 
has been shown to reduce premature intracellular enzyme activation 
(Criddle et al., 2007b).
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A fuller understanding of the mechanisms involved in Ca2+ cell signalling is 
therefore of great importance, as a number of potential therapeutic targets 
are possible, involving either inhibition of Ca2+ entry into PACs or 
inhibition of toxic release from PACs organelles.
1.4.5 Premature trypsinogen activation and enzyme co-localisation
As previously discussed premature trypsinogen activation within the PACs 
has been demonstrated to be a central event in most models of toxic 
premature enzyme activation. However, more recently this central role has 
been challenged, at least in part.
Supporting evidence for the role of intracellular, abnormal activation of 
trypsinogen leading to pancreatitis comes from studies observing events 
when trypsinogen, or the mechanisms that regulate activation, are abnormal. 
This includes: i) mutations of cationic trypsinogen (PRSS1 - the dominant 
human form) that renders trypsinogen more likely to activate and be 
resistant to normal degradation resulting in the human condition of 
hereditary pancreatitis (Whitcomb et al., 1996)(Howes et al., 2005); ii) a
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variant of anionic trypsinogen (PRSS2 - the second most frequent human 
form) which leads to rapid autocatalysis is also protective against 
pancreatitis (Criddle et al, 2007b); iii) Mutations of a trypsin inhibitor 
serine protease inhibitor Kazal type 1 (SPINK 1) increase the risk of 
pancreatitis in transgenic mice (Witt et al.5 2000), and in trypsin activation 
in human cultured cells (Kiraly et al., 2007) through loss of inhibition of 
activated trypsinogen. Overexpression of SPINK 1 ameliorates pancreatitis 
in transgenic mice (Nathan et al., 2005).
It is important to accept that while trypsinogen activation appears to be 
central in most models, recent evidence shows it may not be the only route 
to premature zymogen activation. As recently described, mutations in 
PRSS1-PRSS2 and in CLDN2 already predispose to pancreatitis, which is 
realised when exposure to a suitable aetiological factor occurs (e.g. alcohol) 
(Whitcomb et al., 2012). This forms part of a so-called ‘double-hit 
hypothesis’. In experiments with trypsinogen KO mice (specifically isoform 
7 -/- mice: the equivalent gene of human cationic trypsinogen) there was 
indeed a significant reduction in PAC necrosis and severity of pancreatitis, 
but changes associated with pancreatitis still occurred (Dawra et al., 2011). 
Interestingly local and systemic inflammatory response was largely 
unaffected and it was suggested this was because Nuclear factor kappa B
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(NF-kB) levels were maintained. NF-kB plays an important role in the 
cytokine release associated with inflammation (see later section on 
cytokines). It is also not clear if trypsinogen-7 is the only isoform in mice, 
suggesting the possibility of other isoforms.
There is still debate about how premature trypsinogen activation occurs. 
Following hyperstimulation with caerulein in experimental models it has 
been shown that vacuoles are formed in the apical (or granular) section of 
PACs. These vacuoles result from fusion of lysosomes and zymogen 
granules, and the contents are acidic. Lysosome enzymes, particularly 
Cathepsin B, are co-localised with pro-zymogens and then might be 
involved in initiation of premature activation of trypsinogen (Kukor et al., 
2002) resulting in an activation cascade. However the role of cathepsin B is 
controversial. Evidence supporting its role arises from experimental work, 
where administration of cathepsin B inhibitors, or use of cathepsin B knock­
out mice, leads to a reduction in trypsinogen activation, and a reduction in 
the severity of pancreatitis (Saluja et al., 1999). However it is important to 
note than pancreatitis still occurred in these models, it was just less severe. 
Also there was no decrease in the systemic inflammatory response, meaning 
other organs were still affected (Halangk et al., 2000). Further uncertainty 
for the role of cathepsin B is from older work showing that zymogens and
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cathepsin B co-localise under physiological conditions without premature 
activation within PACs (Tooze et ah, 1991). Cathepsin B does appear to 
have a role in apoptosis and necrosis, secondary to cytochrome c release 
from the mitochondria (at least experimentally in liver hepatocytes) 
(Guicciardi et aL, 2000). It may have a similar effect in PACs, which could 
ameliorate the severity of pancreatitis. Inhibition of cathepsin B 
significantly decreases apoptosis, but not necrosis, in experimental models 
of pancreatitis (Pandol et aL, 2007). Taken together the evidence for the 
importance of the role of cathepsin B is still uncertain.
It had been suggested that, under toxic conditions, damage to the normal 
secretory function of exocytosis allows for a build up of activated zymogens 
within PACs (Perides et aL, 2005), especially once co-localisation occurs. 
This disorder of secretion may contribute to pancreatitis. Inhibition and 
retention of activated zymogens is seen in studies affecting the trypsin- 
activated proteinase-activated receptor-2 (PAR-2) (Pandol et aL, 2007). 
These are G-coupled transmembrane receptors, which aid in secretion of 
activated trypsin, and are therefore considered protective in acute 
pancreatitis (Olejar et aL, 2001). Studies of PAR-2 knock-out mice 
demonstrate more severe pancreatitis (Sharma et aL, 2005). Furthermore 
giving a PAR-2 activating agent in CCK-induced experimental pancreatitis
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is also protective (Singh et al.5 2007). These studies strongly suggest a 
detrimental effect from inability of PACs to excrete activated zymogens.
Ca2+ has a central role in premature trypsinogen activation. This activation 
does not occur in PACs that have had BAPTA (Ca2+ chelator) applied. 
Zymogen granules have high levels of Ca2+, which are thought to be 
important in stabilising pro-zymogens in an inactive state (Nguyen et ah, 
1998)(Yoo et al., 2000). They also have IP3R.S and RyRs on their 
membranes (Gerismenko et al., 1996)(Thrower et al., 2006) and it is through 
activation of these Ca2+ channels by second messengers IP3 and cADPR that 
zymogen granules lose Ca2+ and the pro-enzymes activate prematurely 
(Yang et ah, 2007). Ca2+ release activates K+ entry and a rise in zymogen 
granule (ZG) pH and prepares zymogens for secretion (Thrower et al., 
2006)(Petersen and Sutton, 2006). If toxic signalling occurs then this 
process may become excessive and disordered, leading to premature 
zymogen activation (see figure 1.8).
There are still many aspects to premature zymogen activation that need 
further investigation, such as the role of acidic compartments in premature 
trypsinogen activation, when trypsinogen is more readily activated in
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alkaline conditions (as found in the duodenum). Also intriguing is the 
possibility of endocytosis, where active trypsin is brought back into the 
PAC from the lumen of the acini and then co-localised with lysosomes 
leading to vacuole formation (Sherwood et al., 2007)(Vornina et ah, 2007).
The exact mechanisms of premature trypsinogen activation are still unclear. 
Enzymes co-localisation in acidic vacuoles and toxic Ca signalling have 
been demonstrated to play a role. However the idea of premature 
trypsinogen activation as the only pathway to PACs injury and pancreatitis 
is less certain in recent years. It maybe only one possible pathway (albeit a 
very commonly utilised and important pathway) of a more complex 
response of PACs to injury (see figure 1.9).
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Figure 1.9: Challenge to the central role of trypsinogen activation. A) Diagram 
represents the view that trypsinogen alone leads to PAC damage and pancreatitis. 
B) Diagram represents some of the more recent uncertainties that do not require 
trypsinogen activation to cause PAC damage, and perhaps pancreatitis. These 
include the role of NFkB in release of cytokines, the role of reactive oxygen species 
(ROS) and ER stress.
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1.4.6 CCK stimulation of pancreatic acinar cells
The peptide hormone cholecystokinin (CCK) exists in several forms and is 
an important regulator of the gastrointestinal system. To date the form most 
used in experimental models of pancreatitis is CCK-8, but evidence now 
suggests that CCK-58 may be the more physiologically relevant variant 
(Criddle et al., 2009). CCK-58 is the principal circulating type in humans 
(Eberlein et al., 1987), dogs and rats (Reeve et al., 2003). As discussed 
previously, physiological levels of CCK-8 stimulate zymogen secretion 
form PACs by inducing Ca2+ signalling. Hyperstimulation leads to toxic 
levels of [Ca ]i and the events leading to premature enzymes activation.
Interestingly until recently it was proposed that in humans CCK did not act 
directly on PACs, and acted via stimulation of parasympathetic vagal 
pathways, with release of ACh on PACs leading to enzymes secretion (Ji et 
al., 2001)(Owyang and Logsdon, 2004). This is important as it called into 
question the relevance of experimental work with CCK and its analogues 
(esp. Caerulein) in animal models if human disease was not related to CCK 
stimulation. This position was based on experimental work showing lack of 
Ca2+ signalling within isolated human PACs exposed to CCK (Ji et al, 
2001).
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However subsequent work showed that human PACs do exhibit CCK 
receptors on their surface membranes (Galindo et ah, 2005). This was 
followed up by work from our group at Liverpool that showed isolated 
human cells do respond to both CCK-8 and CCK-58, at physiological and 
supra-maximal levels. We suggested that the quality of the human cells at 
the time of experimentation was vital (Murphy et al., 2008). These results 
confirmed the similarity between murine and human models in respect to 
the role of CCK as a regulator of PACs zymogen secretion, and the 
validation of experimental animal models in studying pancreatitis.
1.4.7 The role of cytokines in acute pancreatitis
Events that occur after acinar cell injury may determine the severity of acute 
pancreatitis. A severe inflammatory response, initially with accumulation of 
neutrophils within the pancreas itself, but subsequently involving other 
organs, is seen in severe acute pancreatitis. These systemic effects are 
brought about by release of a ‘cytokine storm’. PACs cytokines include 
tumour necrosis factor alpha (TNF-a), interleukins 1 and 6 (IL-1, IL-6) and
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platelet activating factor (PAF) (Pandol et al., 2007). Cytokines are immune 
modulating cell-signalling protein molecules, that are released from cells 
when they are damaged, and recruit inflammatory cells such as neutrophils 
and macrophages. The release of cytokines appears to be independent from
'ji
trypsinogen activation, but maybe dependent on toxic Ca signalling. Their 
release is regulated by signalling systems including: nuclear factor kappa B 
(NFkB), activator protein-1 (AP-1) and phosphatidylinositol-3 kinase (PI-3 
kinase). They recruit leucocytes to the site of injury on order to deal with 
damaged cells, and initiate the reparative process. However during a 
cytokine storm this process is overstimulated and the inflammatory cells 
recruited release further cytokines leading to a positive feedback loop and 
more damage within the pancreas.
Attempts to inhibit the signalling systems initiating cytokine release have 
previously studied NF-kB (Rakonczay et al., 2008b). Inhibition of NF-kB 
has demonstrated mixed results: in most cases NF-kB activation was 
harmful (Pandol et al., 2007), but in one study it was protective (Steinle et 
al., 1999). NF-kB also has others roles in the inflammatory response, 
including upregulating adhesion molecule ICAM-1 (Zaninovic et al., 2000). 
Some pancreatic zymogens themselves may activate NF-kB, though the 
evidence for this is weak at present (Pandol et al., 2007).
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Eventually the process may be counteracted by anti-inflammatory cytokines 
(e.g. IL-10, IL-1 receptor antagonist) and become self-limiting. But in 
severe disease the balance of pro- and anti-inflammatory cytokines favours 
pro-inflammatory cytokines and allows progression to a systemic illness, 
affecting organs distant to the pancreas, and leading to the systemic 
inflammatory response syndrome (SIRS) (Simovic et aL, 1999). This most 
frequently affected organ outside of the pancreas is the lung, and the 
resulting adult respiratory distress syndrome (ARDS) is a well-recognised 
cause of death in severe pancreatitis in humans.
The mechanisms involved in cytokine release are complex and there are 
multiple interactions between various pathways compounding a fuller 
understanding. It would seem to be that an ability to stop pro-inflammatory 
cytokine release and decrease the severity of the disease would be beneficial 
in acute pancreatitis.
1.4.8 Reactive oxygen species and cell stress
Reactive oxygen species (ROS) are highly reactive molecules containing 
oxygen ions and peroxides that form as a by-product of aerobic respiration
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and have roles in cell signalling. However when cells, including PACs, are 
damaged ROS levels can rise rapidly leading to the condition oxidative 
stress (or cell stress), where the PACs are unable to nullify ROS levels. This 
is turn leads to excess free radicals and peroxides directly damaging the 
proteins, lipids and DNA that make up the functioning cell machinery. 
Experiments show this happens early in the course of experimental 
pancreatitis (Weber et al., 1998). Experimentally anti-oxidants have been 
shown to decrease the severity of pancreatitis in animal models, however 
this has not been seen in corresponding human trials (Siriwardena et al., 
2007). Indeed these human trials have even shown an adverse outcome with 
use of anti-oxidants. Currently the mechanisms of ROS-mediated damage 
are still unclear.
Finally there maybe a relation between ER Ca2+ levels and cell stress, 
resulting in mal-production of proteins in the ER. This is turn has been 
suggested to lead to excessive Ca2+ release from the ER into the cytosol and 
the familiar effects of sustained, toxic [Ca2+]j levels, as well as increasing 
NF-kB levels (Pahl, 1999)(Panchen, 2001).
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1.5 Caffeine
Caffeine is a xanthine alkaloid that acts a stimulant in mammals and is 
commonly consumed by humans in infusions of coffee, tea, some soft 
drinks and is present is some foods, such as chocolate. It is absorbed rapidly 
from the gastro-intestinal tract and passes freely across all biological 
membranes (Lachance et ah, 1983). Peak plasma caffeine concentration is 
reached between 15 and 120 minutes after oral ingestion in humans (Arnuad 
and Welsch, 1982) and a single cup of coffee is though to provide a dose of 
0.4-2.5 mg/kg (which equates to 1-10 pM). For doses lower than lOmg/kg 
the half-life in rodents and murine models has been found to be 
approximately 1 hour (Bonati et al., 1984) and approximately 3 hours in 
adult humans (Arnaud, 1987). A cup of coffee is thought to contain 
approximately 80-135 mg caffeine, with tea containing 22-74 mg (Chin et 
al., 2008).
It has been shown that caffeine has effects on [Ca2+]j signalling, and thus on 
potentially on acute pancreatitis (Petersen and Sutton, 2006)(Gerasimenko 
et al., 2009). As previously detailed a range of stimuli, associated with
'74-triggering the events of acute pancreatitis, lead to elevated, sustained [Ca ]i 
levels. This pathological Ca2+ signalling requires activation of IP3R 
channels (sited on endoplasmic reticulum), which release Ca stores from 
the ER and potentiate the toxic elevation of [Ca2+]i (Gerasimenko 2009).
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Caffeine acts an IP3R inhibitor (Petersen and Sutton, 2006) (Griddle et ah, 
2007b) and may also inhibit the production of the second messenger IP3 
(Toescu et ah, 1992). Caffeine may have others routes of action on PACs 
including: i) inhibition of cyclic adenosine monophosphate
phosphodiesterase, interfering with cAMP recycling (Wu et ah, 2009); ii) 
inhibition of adenosine A1 receptor, which has been shown to be protective 
in experimental pancreatitis (Fredholm et ah, 1999)(Satoh et ah, 2000) and 
may be involved in cystic fibrosis transmembrane conductance regulator 
type pancreatitis (DiMagno et ah, 2010)(Steiner et ah, 2011); Caffeine has 
been shown by our group to inhibit Ca2+ entry through store-operated 
channels (SOC) in the PACs membrane (Cane et ah, unpublished data). This 
body of work suggests caffeine has theoretical potential as a therapeutic in 
human pancreatitis, if administration in vivo produces the same inhibition 
seen in vitro.
Caffeine is metabolised in the liver by the cytochrome p450 oxidase enzyme 
system. The main metabolites are paraxanthine (1,7-dimethylxantine), 
theobromine (3,7-dimethylxanthine) and theophylline (dimethylxanthine) 
(see figure 1.10). Paraxanthine is the most commonly produced metabolite. 
Is is possible that the protective effects in pancreatitis may be related to
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metabolite activity. The results chapter details experiments with caffeine in 
caerulein murine model of in vivo acute pancreatitis.
Caffeine
Paraxanthine Theobromine Theophylline
(84%) (12%) (4%)
Figure 1.10: Common metabolites of caffeine. Paraxanthine is most commonly 
formed, at 84%.
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1.6 Summary
Acute pancreatitis is a complex disease that so far has resisted attempts at 
amelioration with therapeutics. Although understanding is increasing there 
are still many areas that remain unclear. Much of our current understanding 
has been drawn from the many varied animal models, mostly from murine 
and rodent models. Although there is much commonality between 
mammalian models, it is also clear that many inter-species differences do 
exist, meaning pathways and mechanisms can vary between species. This is 
the likely explain why many promising treatments, that ameliorate disease 
in experimental animal models, do not to translate to the treatment of human 
disease. Nevertheless continued use of animal models is vital to rapidly 
push forward understanding and highlight promising targets of therapy in 
human disease.
However work must been done in parallel with human tissue, as the ability 
to replicate findings from animal tissue would help identify plausible 
therapeutic targets. Work with human tissue will clarify which mechanisms 
are shared between mammalian species, and thus which mechanisms need 
to be focused on, and which are not found in human tissue and are not 
relevant. Whilst obtaining human tissue is technically and ethically
88
problematic, it is vital to further understanding of acute pancreatitis. This is 
ideally undertaken in the setting off a multidisciplinary collaboration 
involving basic scientists and clinicians with an appropriate spread of 
technical expertise.
The role of apoptosis and necrosis, and the interconnected importance of 
mitochondrial metabolism, has been recognised as important in determining 
the severity of acute pancreatitis. However previous opinion that apoptosis 
is protective, and necrosis detrimental, in acute pancreatitis maybe 
simplistic. Apoptosis per se may not be protective in all circumstances and, 
while many of the components of cell death pathways have been elucidated, 
a full understanding of all the possible interactions of these components is 
far from clear. Some of these mechanisms have been elucidated in vitro, but 
there are still many aspects of these pathways that are unclear. In addition it 
is unknown if these pathways work the same way in vivo as in vitro, and so 
experimental work is required in vivo to further explore their importance in 
living animals.
Caffeine has promising inhibitory effects on mechanisms known to cause 
pancreatitis in vitro (namely toxic Ca2+ signalling). To date its role in 
experimental in vivo pancreatitis has not been tested. As caffeine is
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currently used safely as a therapy in human disease (for the unrelated 
neonatal apnoea syndrome) it has potential to be used as a therapy to 
ameliorate acute pancreatitis.
1.7 Aims and objectives
1) To test whether cholecystokinin (CCK) stimulates signalling responses 
directly on isolated murine and human pancreatic acinar cells and whether 
this stimulation ultimately leads to secretion. In addition to test whether 
CCK-58 stimulates similar responses to the more established CCK-8.
The null hypothesis is that CCK does not act directly on pancreatic acinar 
cells and another pathway is involved.
2) To test the effects of Bcl-2 protein family gene knock-out on caemlein- 
induced murine experimental pancreatitis.
The hypothesis to be tested is that Bak and Bax are considered pro- 
apoptotic, and apoptosis is considered protective in acute pancreatitis. So 
Bak or Bax knock-out should result in decreased apoptosis and worsening
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of severity of induced pancreatitis. The null hypothesis is that Bak or Bax 
knockout has no effect or protects against acute pancreatitis.
The hypothesis to be tested is that Bcl-2 is considered anti-apoptotic so that 
knock-out should result in an increase in apoptosis and improvement in 
severity of induced pancreatitis. The null hypothesis is that Bcl-2 knock-out 
has no effect or shows increased severity in acute pancreatitis.
3) To test the effects of administering caffeine in caerulein-induced murine 
experimental pancreatitis. Caffeine is known to inhibit Ca signalling and 
stops changes in isolated pancreatic acinar cells associated with pancreatitis. 
The hypothesis to be tested is that caffeine is protective against caerulein- 
induced murine experimental pancreatitis.
The null hypothesis is that caffeine has no effect or increases the severity of 
caerulein-induced murine experimental pancreatitis.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Materials
2.1.1 Equipment
The water bath used for incubation where indicated was a Grant OLS-200, 
Grant instruments, Cambridge. A Fisher PF-203 was used for determining 
mass of reagents in the making of solutions and in the weighing of sections 
of pancreas. A Heraeus Biofuge Stratos (Kendro Laboratory Products, 
Sollentum, Germany) was used for centrifugation where necessary during 
all experiments. A Fluorescence Spectrometer LS50B (PerkinElmer, 
Massachusetts, USA) in conjunction with a Circulator C-85A, Techne 
instruments (Bibby Scientific, Stone, Staffs) was employed for the analysis 
of trypsin activity. Bradford assays were performed utilising a 
spectrophotometer. Light microscope was used for analysis of murine 
pancreatic tissue.
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2.1.2 Confocal microscopy
Confocal microscopy allows measurement of narrow focal sections of an 
object, rather than collecting all available light as in standard fluorescence 
microscopy. Standard fluorescence microscopy is not sensitive enough to 
detect the small, localised changes occurring within a cell, such as localised 
Ca2+ signals. Measuring fluorescence is performed by excitation of the 
target molecule (fluorophore) with laser light of a specified wavelength, 
exciting the fluorophore to a higher state. This is followed by collection of 
the emitted photons from the fluorophore when it returns to a lower energy 
state. The emitted light is always of a lower energy level (Stoke’s shift) (and 
therefore longer wavelength of light). This longer wavelength allows 
emitted light to be separated from the excitation light, by use of an emission 
pinhole. Only light from the narrow focal plane passes through to the 
detector. In the context of isolated cell work this means very specific 
localised regions of the cell can be studied, such as zymogen granules.
The two confocal microscopes used in our group were a Zeiss LSM 510 
system and a Leica TCS SP2 (AOBS). Both systems are laser scanning 
confocal microscopes. Fluorescent signals were recorded using a 63x water 
immersion objective lens with a numerical aperture of 1.2 (see figure 2.1).
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Figure 2.1 : Photograph demonstrates the Zeiss LSM 510 confocal microscope, housed 
in a Faraday cage and placed on an air table to reduce vibrations. The perfusion 
system is seen attached to the cage in the upper left hand of the image.
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2.1.3 Consumables
Coverslips from Merck Ltd, UK
Cuvettes for fluorescence spectroscopy from Sigma-Aldrich 
Eppendorf Vials from Eppendorf, Hamburg, Germany 
Forceps from Sigma-Aldrich Company Ltd, Poole, UK 
Magnetic stirrers (small) from Sigma-Aldrich Co.
Needles (25G) from Becton Dickson UK Ltd, Oxford, UK 
Pippettes from Anachem 
Pipette tips from Anachem 
Scissors from Sigma-Aldrich Co.
Syringes from Beckton Dickinson UK Ltd, Oxford, UK 
Teflon/glass homogeniser 
Formalin pots
2.1.4 Chemicals and Reagents
Albumin (bovine serum) from Sigma-Aldrich Co.
Anti-mouse Caspase 3 anitbody (rabbit) from R&D systems, Germany
Bradford protein assay reagent from Biorad, Kernel Hampstead UK
Boc-Gln-Ala-Arg-MCA Peptide substrate from Peptide International Inc, 
Kentucky, USA
Caerulein from Sigma-Aldrich Co.
Calcium Chloride (CaCU) from Sigma-Aldrich Co.
Caffeine from Sigma-Aldrich Co.
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Citric Acid Buffer from Sigma-Aldrich Co.
3,3-Diaminobenzidine (DAB) from Sigma-Aldrich Co.
Dimethyl Sulfoxide (DMSO)
Ethanol from Sigma-Aldrich Co.
Formalin 10% solution from Sigma-Aldrich Co.
Goat serum from Dako, Glostrup, Denmark 
Haematoxylin solution from Sigma-Aldrich Co.
Hydrochloric acid (HC1) from Sigma-Aldrich Co.
Methanol from Sigma-Aldrich Co.
MOPS (3-(N-morpholino)propanesulfonic acid) from Sigma-Aldrich Co. 
Mouse serum from Dako, Glostrup, Denmark
PBS (Phosphate Buffered Solution) constituents from Sigma-Aldrich Co. 
Sodium chloride (NaCl) from Sigma-Aldrich Co.
Sodium hydroxide from (NaOH) from Sigma-Aldrich Co. 
Tris(hydroxymethyl)aminomethane from Sigma-Aldrich Co.
Tris Buffered Saline (TBS) components from Sigma-Aldrich Co. 
Tween-20 from Sigma-Aldrich Co.
Trypsin (Bovine) from Sigma-Aldrich Co.
Vector Stain (Elite ABC kit) from Vector Laboratories Ltd, Peterborough, 
UK
Xylene from Sigma-Aldrich Co.
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2.1.5 Animals
All experimental mice were bred and housed in clean conditions in the 
Biomedical Services Unit at constant temperature (23±2°C) with 12-hour 
light/dark cycle and free access to standard laboratory pellet feed and water. 
All experiments were conducted in accordance with a valid project licence 
from the Home office under the terms of the Animals (Scientific 
Procedures) Act 1986.
C57BL/6 male mice were purchased through the Biomedical Services Unit 
at the University of Liverpool, from a licenced supplier (Charles River UK 
Ltd, Margate).
Knockout mice (Bcl-2, Bak and Bax) were used from the inbred stock at the 
Biomedical Services Unit at the University of Liverpool, in collaboration 
with the Division of Gastroenterology.
Bak wild-type and homozygously null mice were obtained from the 
Division of Gastroenterology, from a stock bred in the Biomedical Services 
Unit, University of Liverpool. These were originally derived from
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embryonic stem cells microinjected into C57BL/6 blastocysts (Pritchard et 
al, 1999) and were considered close enough to C57BL/6 stock for the latter 
to be used as controls.
Bcl-2 wild-type and homozygously null mice were obtained from the 
Division of Gastroenterology, from a stock bred in the Biomedical Services 
Unit, University of Liverpool. These were originally derived from 129Sv 
E14 and D3 embryonic stem cells microinjected into C57BL/6 blastocysts 
(Pritchard et al, 1999).
The Bax wild-type and homozygously null mice were obtained from the 
Division of Gastroenterology, from a stock bred in the Biomedical Services 
Unit, University of Liverpool. These were originally derived from 129Sv 
RW-4 embryonic stem cells implanted into C57BL/6 blastocysts and 
maintained on this background (Pritchard et al, 1999).
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2.2 Methods for isolated murine and human PACs experiments 
2.2.1 Isolation of murine pancreatic acinar cells
Freshly isolated murine PACs were obtained from the pancreases of adult 
male CD1 mice (age 21-30 days and weight 30-35g). The mice were 
sacrificed by a schedule 1 action, with a stunning blow to the head and 
cervical dislocation, in accordance with the Animal (Scientific Procedures) 
Act 1986. The flank was washed with 100% ethanol to wet the fur and 
prevent contamination. The pancreas was removed through a laparotomy, 
dissected from surrounding structures and placed into extracellular solution. 
The extracellular solution contained (in mM): 140 NaCl, 4.7 KC1, 1.13 
MgCli, 1 CaCl2, 10 D-glucose and 10 HEPES (adjusted to a pH of 7.35 
using NaOH). All chemicals were of the highest grade, obtained from 
Sigma, Gillingham, UK. Collagenase (Worthington, Lome laboratories, 
Reading) was then injected into the pancreas tissue at a dose of 200U/ml, 
and the pancreas was incubated in a water bath at 37°C for 15 minutes. At 
the end of the incubation period the pancreas was transferred into a small 
falcon tube, containing 5 ml fresh extracellular solution, and agitated with a 
pipette to break the pancreas down into smaller constituent parts. The 
sample was purified for PACs by: centrifugation of the suspension at 1000 
revs for 1 minute. The supernatant was discarded, the pellet resuspended in 
extracellular fluid and filtered, before being further centrifuged and the
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process repeating 2-3 cycles. The final pellet containing PACs as single cell, 
doublet and smaller clusters was then re-suspended in 2ml of extra-cellular 
solution. All experiments were performed at room temperature and within 3 
hours of isolation.
2.2.2 Isolation of human pancreatic acinar cells
Human pancreatic tissue was obtained from patients undergoing pancreatic 
resections at the Royal Liverpool University Hospital, Liverpool, UK, 
between Jan 2004 and Feb 2008. The study had approval from the Liverpool 
Adult Local Research Ethics Committee (Ref:03/12/242/A). All patients 
were provided with verbal and written information regarding the study on 
the night of admission (usually the day prior to surgery) and then informed 
consent was taken on the day of surgery. The sample specimen was taken 
from the resected pancreas specimen, so that no unnecessary extra 
pancreatic tissue was taken from the patient. Ideally this was taken away 
from the area of pathology, to ensure tissue was as normal as possible (other 
means to optimise collection of healthy tissue are described below, page 
101). It was found that sub-optimal pancreas tissue came from patients with 
disease obstructing the pancreatic duct and/or jaundice (bile-duct
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obstruction), suggesting these pathologies elicit damage throughout the
pancreas.
Freshly isolated human PACs were prepared in a similar manner as to 
murine isolated PACs as detailed above. However several modifications 
were required to ensure good quality cells. Human pancreas samples were 
obtained fresh from within the operating theatre at the time of surgery. Once 
the pancreas resection was performed a small section was cut, without 
delay, by the surgeon from the resected specimen. This was performed with 
a scalpel blade, and not with a diathermy instrument, to reduce damage from 
heat injury. The specimen was immediately washed of blood (to reduce the 
chance of residual inflammatory cells), placed in extracellular fluid and 
transported on ice. In order to maintain the specimen in an optimal 
condition the extracellular solution contained enzyme inhibitors (protease 
inhibitors (ROCHE, USA) and the trypsin inhibitor Benzamidine 
(Worthington Biochemical)) and also pyruvate to optimise mitochondrial 
function. The time to transfer to the lab was under 10 minutes.
Once in the lab the human pancreas was injected at several points with 
200U/ml collagenase, with ImM benzamidine, and then cut into small
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sections and incubated at 37°C form 15 minutes. The collagenase was then 
drained and washed off and the sample resuspended in extracellular solution 
and purified by serial centrifugation, discarding the supernatant, 
resuspending the pellet, filtering and then repeating the process usually 3 
times (as per the method used in the preparation of murine isolated cells). 
All experiments were performed within 3 hours of preparation of the cells, 
and cells kept at 4°C until used.
2.2.3 Loading of fluorescent dyes and measurement of secretion
Once the isolated PACs were prepared, as described in the previous two 
sections, they were loaded with fluorescent dyes (dyes dissolved in dimethyl 
sulphoxide (DMSO)). This was achieved by adding an appropriate dose of 
dye to the 2ml of suspended isolated PACs, covering with light excluding 
foil and incubating at room temperature with gentle agitation. At the end of 
the loading period the dye was washed out with more extracellular fluid and 
the cells centrifuged and resuspended.
Quinacrine dye was loaded into the PACs at a concentration of lOpM (2pi 
of 10pm dye to a 2ml suspension of isolated PACs), and incubated at 37°C
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for 10 minutes, and washed out as outlined. Quinacrine was preferentially 
concentrated in zymogen granules (see figure 2.2) and was expelled from 
the zymogen granules during secretion. Its fluorescence was measured using 
a confocal microscope (figure 2.2) and the loss of fluorescence when the 
PACs were stimulated indicated secretion (Myoung et al., 2004). 
Fluorescence measurements were expressed either as absolute values (where 
appropriate) or as normalized changes from basal fluorescence (called the 
F/Fo ratio), where Fo represents the fluorescence recorded at the specific 
time points. Other dye used was Fluo-4, for detecting Ca2+ signalling and 
loading is further detailed in Chapter 3.
During experiments the PACs suspension were placed on a thin glass 
coverslip, which was then fixed to a Perspex perfusion chamber. A short 
time period is allowed to that the PACs could settle and fix to the coverslip. 
Extracellular solution was then fed into the chamber via a gravity-fed 
perfusion system, consisting of plastic syringes (with two-way taps to 
control flow) connected to the perfusion chamber by thin silicon tubing. 
Low power suction tubing is applied to the other end of the chamber to 
provide a continuous one-way direction of flow. Stimulating agents (i.e. 
CCK-8, CCK-58) and/or receptor inhibitors were added during the 
experiments and their actions on the PACs secretion observed.
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Figure 2.2: A) Quinacrine fluorescence. Typical view of murine pancreatic acinar 
cells loaded with quinacrine and fluorescence captured using a confocal 
microscope. Quinacrine is concentrated in the zymogen granules, which are 
concentrated in the apices of the PACs. B) Perfusion chamber set up on microscope 
stage with multiple perfusion tubing running in from the right and low-power 
suction tubing leading away to left.
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2.3 Methods for experimental in vivo murine pancreatitis models
2.3.1 Induction of experimental pancreatitis in vivo
Mice were fasted over night before induction of pancreatitis (between 12-16 
hours), but received free access to water. Experimental pancreatitis was 
induced through the well described method of hourly intra-peritoneal 
caerulein (Sigma) administration. The required concentration of caerulein is 
50pg/kg/hr (Niederau et ah, 1985). Caerulein was dissolved in 0.9% saline 
to a concentration of lOpg/ml. Thus a 30g mouse would require 1.5pg per 
injection, or 0.15 ml. Injections were administered with a 1ml syringe to 
facilitate the accurate administration of such small volumes. Opioid 
analgesia was given with the 1st injection (Buprenorphine 0.1 mg/kg).
To administer intra-peritoneal injections mice were held by the neck scruff, 
between forefinger and thumb, and the left hind leg held straight with the 
ring and little finger. An alcohol swab was applied to the abdomen before 
each injection, and the injection site placed in either the left or right lower 
lateral parts of the abdomen, to avoid injuries to the liver or stomach. 
Injections were given using a small 25G needle.
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With the exception of the control group, all mice received hourly intra- 
peritoneal injections. Those mice in the four hour experimental group 
received only four injections. Those in the eight, twelve and twenty-four 
hour experimental groups all received seven hourly injections, with the 
timing for the experiment starting with the first injection at zero hour (see 
Table 2.1 below).
Ohr Ihr 2hr 3 hr 4hr 5hr 6hr 7hr 8hr 9hr lOhr 11 hr 12hr 24hr
4hr + + + *4“ end
8hr + + + + + - end \
12hr + + + + + + + - - - - - end <
24hr + + + + + + + - - - - - ^ end
Table 2.1: Caerulein injection schedule for different experimental time groups. (+) 
denotes one injection of caerulein 50pg/kg given. (-) denotes no injection given, (end) 
denotes end of experiment with harvest of pancreas.
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2.3.2 Removal of pancreas
Mice were euthanised by CO2 inhalation, in accordance with the Animal 
(Scientific Procedures) Act (1986). The pancreas was removed from each 
mouse by an incision in the left flank. It was identified by its location 
between the duodenum and the spleen. It was carefully cut from 
surrounding tissues and immediately weighed. This weight was used to 
obtain pancreas weight as a percentage of whole body weight: a proxy for 
oedema. The pancreas was divided into three approximately equal portions: 
head, body and tail. The weight of each portion was recorded. The head 
section was used for histology, the body of the pancreas used for trypsin 
activity analysis and the tail for calculation of wet weight.
2.3.3 Measurement of oedema
After weighting the tail section of the pancreas was placed onto a dry glass 
slide and placed in an oven at 80°C for 72hrs (until desiccated). The dry 
weight of the desiccated pancreas section was measured and the water loss 
calculated as the difference between the original weight and the dry weight. 
The pancreatic tissue wet to dry weight ratio was expressed as:
(wet weight-dry weight)/wet weight xl00%
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2.3.4 Analysis of serum amylase
Mice were euthanised by CO2 inhalation, in accordance with the Animal 
(Scientific Procedures) Act (1986). This method was chosen because of the 
requirement of a sufficient quantity of blood for serum amylase analysis. In 
pilot studies stunning and cervical neck dislocation had resulted in internal 
bleeding with subsequent drop in circulating blood volume, making 
sufficient blood collection difficult. Use of CO2 allowed the vascular system 
to remain intact. Cardiocentesis could be performed using a 1ml syringe 
with a 23G needle under the sternum. This resulted in a 0.5-1.0 ml sample, 
depending on the size of the individual mouse. The samples were placed in 
an eppendorf vial on ice and subsequently centrifuged at 1500g for 20 
minutes. Serum was then pipetted off into a new, cooled eppendorf vial. 
Serum samples were stored in the freezer (-200C) until analysed. Analysis of 
serum amylase was carried out by the Department of Clinical Chemistry in 
The Royal Liverpool University Hospital, using a kinetic method with 
Roche automated clinical chemistry analyzers (GMI, Leeds, UK). The 
results were expressed as IU/L.
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2.3.5 Preparation of histological slides
The body section of the pancreas was placed into vials containing 10% 
formalin (Sigma-Aldrich Co.) for fixation. The fixed tissue was embedded 
in paraffin, then sectioned at 5 pm. Two slides were prepared per block. One 
was stained with haematoxylin and eosin (H&E) for histological grading 
and the other left unprepared for immunohistochemistry staining with anti- 
caspase 3 antibody. Slide preparation and H&E staining was carried out by 
the Department of Pathology in the University of Liverpool.
2.3.6 Histological scoring of severity of pancreatitis
A histological score was developed to quantify morphological changes 
induced by caerulein in murine pancreas. Most groups with a consistently 
recognised high standard of work in experimental pancreatitis use similar 
morphological changes in pancreatic tissue (Niederau et ah, 1985; 
Spormann et al., 1989; Dembinski et ah, 2003; Nathan et al., 2005). The key 
standard components of these scores are inclusion of: (1) rating the degree 
of histological changes, notably oedema, neutrophil infiltration and acinar 
necrosis; (2) blinded assessment of severity; and (3) some form of quality
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assurance (e.g. two blinded assessors, with measures to ensure conformity 
in rating; checking similar* changes in other parameters e.g. serum amylase). 
Some groups have assessed the degree of vacuolisation, but this change is 
more dependent on the timing of sampling so this was not used. The scoring 
system adopted used the three principal separate morphological changes 
(adapted from previous work e.g. Nathan et al 2005): oedema, inflammatory 
infiltration and necrosis. Each parameter was scored from 0-3, as set out in 
the Table 2.2 below.
Ill
Parameter Morphological Change Score
Oedema Nil 0
Interlobular 1
Interlobular and moderate intralobular 2
Severe interlobular and intralobular 
(acinar disruption
3
Inflammatory
infiltration
Absent 0
Perivascular infiltration only 1
Perivascular and scanty diffuse
infiltration
2
Diffuse infiltration 3
Necrosis Absent 0
<5% 1
5-25% 2
>5% 3
Total (0-12)
Table 2.2: Criteria used to score histopathological severity of caerulein- 
induced experimental murine AP (using H&E stained slides).
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This provided a combined histological severity score ranging from 0-12. 
Two blinded assessors, who had previously received training in grading 
histological severity in pancreas tissue, scored slides. Using a light 
microscope, with two separate viewing ports, assessors simultaneously 
viewed slides, at a magnification of xlOO. Assessors were blinded to the 
nature of each slide, did not communicate during scoring and viewed 
approximately 30 slides per session, to ensure a mix of experiments. 10 
separate fields were scored per slide and then meaned for an overall slide 
score. The meaned combined score of both assessors was the final score for 
the slide. This is ‘interval data’ and an assumption is made it is parametric 
(accepting that the groups have small sample sizes).
2.3.7 Immunohistochemistry for caspase-3 staining
To identify apoptotic cells, and discriminate them from necrotic cells, 
detection by immunohistochemical labelling of active caspes-3 was 
employed. Slides containing 5 pm sections of pancreas tissue, embedded in 
paraffin, were prepared by the Department of Pathology in the University of 
Liverpool. Staining for caspase-3 was carried out by the author for the first 
batches of slides and whilst the protocol was being developed. Subsequently 
slides were stained by the Department of Pathology, University of Liverpool
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using the same primary antibody, supplied by the author. The protocol for 
staining of murine pancreatic tissue for easpase-3 is as follows.
The slides were dewaxed in Xylene for 10 minutes then immersed in 100% 
ethanol for 3 minutes. Next they were immersed in 3% H2O2 in methanol 
for 45 seconds. A rehydration series in alcohol followed (90%, 70%, 40% 
for 2 minutes each). The slides were then washed in water followed by 
Phosphate Buffer Solution (8 g NaCl, 0.2 g KC1, 1.44 g Na2HP04, 0.24 g 
KH2PO4, 1 litre H2O [pH 7.4]) (PBS). Epitope retrieval was performed by 
immersing in citric acid buffer (2.94 g/L [pH 6.0] covering and heating at 
maximum power in 800w microwave for 20 minutes (stopping half way to 
ensure buffer solution covering slide and adding more buffer if necessary). 
Slides were cooled in running water and, after two further 5 minute washes 
in PBS, the tissue was blocked with 10% goat serum in TBS-Tween (1 litre 
dH20, 6.05 g Tris, 8.5 g NaCl, 2ml tween-20 [7.4]) for 45 minutes at room 
temperature. The excess liquid was washed off and the slides were 
incubated with the primary antibody (active caspase-3 antibody in 1:1000 
solution with 10% goat serum/TBS-Tween20) overnight at 4°C.
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After overnight incubation the slides were first washed in TBS-Tween20 
then incubated with the secondary antibody (biotin labelled anti-rabbit 
secondary antibody in 1:200 solution with 5% mouse serum/TBS-tween) for 
40mins at room temperature. After two further TBS-Tween20 washes the 
slides were incubated with Vectastain ABC elite for 30 minutes at room 
temperature. After washing with TBS-Tween20 and then PBS the slides 
were incubated with DAB 0.07% in PBS for 3 minutes at room temperature. 
After a further PBS wash the slides are immersed in 80% methanol for 10 
minutes then transferred to haemotoxylin and counter-stained with agitation 
for 4 minutes. After rinsing with water slides were dehydrated by immersion 
first in 90% ethanol and then 100% ethanol. Lastly slides were transferred 
to xylene for 5 minutes before being mounted with slide covers and dried.
Ten random fields were imaged at magnification 200x from each slide. The 
images were processed using ImageJ software that splits positive caspases-3 
stained nuclei/cytoplasm into one channel and all other stained nuclei into 
another channel. The proportion of apoptotic cells was defined by the mean 
ratio of positively stained cells out of the total nuclei.
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2.3.8 Use of caffeine in experimental models
Caffeine powder (Sigma-Aldrich) was dissolved in extracellular solution 
and made into 2 mg/ml stock. During murine experimental models the 
appropriate dose was made by further dilution in extracellular solution 
depending on the weight of the individual animal. Concentrations used were 
1 mg/kg and 10 mg/kg. Higher doses (50 mg/kg and 100 mg/kg) were 
trialled, but side effects were too severe and experiments ceased. Caffeine 
was administered IP hourly, with caerulein, and the animal sacrificed at 8 
hours. Further details regarding caffeine administration are described in 
chapter 5.
2.3.9 Statistical analysis
Results in figures are expressed as mean ± standard error of mean (SEM). 
Normally distributed parameters (e.g. pancreatic oedema, amylase and 
trypsin measurements) were analysed using student’s /-test. Statistical 
significance was set at <0,05. Microsoft Excel, Origin 2.6 and SPSS 2.0 
were used for statistical processing and graphics.
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Chapter 3
Direct activation of Ca2+ signalling and 
zymogen secretion from isolated murine and 
human pancreatic acinar cells in response to 
stimulation by cholecystokinin-8 and 
cholecystokinin-58
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3.1 Introduction
Cholecystokinin-8 (CCK-8) and its analogues (caerulein) are still one of the 
most widely employed experimental models. Extensive use of CCK- 
8/caerulein in murine and rodent models have shown that physiological 
levels (range 1-20 pM) of neuro-hormonal stimulants (e.g. Ach, CCK-8) 
elicit Ca signalling that in turn controls zymogen secretion (Petersen and 
Tepikin, 2008).
However there has been some controversy as to the relevance of CCK 
stimulation in human disease. There is doubt regarding a direct clinical 
equivalent of CCK-induced human pancreatitis and there has been 
controversy as to whether CCK acts directly on PACs or acts distally via 
stimulation of vagal pathways, which in turn stimulate PACs (Ji et al., 
2001)(Owyang et al., 2004). Both scenarios provide some difficulty in 
continued employment of CCK/caerulein experimental models. To date 
there has been little work with isolated human PACs to determine if human 
PACs have the same mechanisms as murine PACs, mainly due to the 
obvious difficulty in safely sampling live human pancreas tissue (Miller, 
1996). In addition there is some debate regarding which subtype of CCK is 
most relevant. CCK-8 is most widely employed in murine models, though 
there has been some evidence that CCK-58 may be more active
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physiologically and has previously been shown to circulate in humans 
(Eberlein et aL, 1987) and is the only form found in rats (Reeve et aL, 
2003). In murine models at physiological levels (1-20 pM) CCK-8 induces 
focal apical Ca2+ signalling coupled to mitochondrial energy production and 
secretion. However at supra-maximal levels of stimulation (lOnM) it leads 
to pancreatitis and is, thus, widely employed as a pancreatitic model. It is 
necessary to compare CCK-8 and CCK-58 effects on isolated murine and 
human PACs to further ensure relevance of the sub-types. This chapter 
details experiments that investigated CCK-58 effects on murine isolated 
PACs and compared to previously established CCK-8 effects. Ca2+ 
signalling, mitochondrial metabolism and quinacrine excretion were all 
recorded at both physiological and supra-maximal doses of CCK-8 and 
CCK-58
In order to investigate human PACs response to CCK-8 and CCK-58 it was 
necessary to work in collaboration. The experimental work was undertaken 
by our group at the University of Liverpool and we collaborated with the 
University of California and University of Texas Health science centre, 
USA, which supplied CCK-58. Within our group, work was undertaken on 
different mechanisms of PACs stimulation in parallel. Part of our group 
worked on demonstrating that Ca2+ signalling was indeed induced by CCK
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stimulation. It is necessary to provide evidence that this signalling is in turn 
linked to release of zymogens from PACs, making it necessary to 
demonstrate secretion in response to CCK stimulation. This chapter details 
the experiments undertaken to show this secretion, using quinacrine loading 
of zymogen granules in isolated human PACs and recording changes in the 
levels of fluorescence when PACs were stimulated by CCK. Similar 
techniques have been reported previously in isolated murine PACs, which 
when stimulated with ACh showed a drop in apical quinacrine secretion of 
approximately 20 per cent (Belan et al., 1996)(Myoung et al., 2004) (See 
figure 3.1). Secretion is an active process and (to strengthen the case for 
CCK stimulation leading to secretion) recording autofluorescence of NADH 
in perigranular mitochondrial belts also assessed mitochondrial activation. 
All experiments took place in the presence of atropine and tetrodotoxin 
(which blocks voltage-gated Na+ channels) to eliminate possible effects 
from neuro-transmitter pathways other than CCK (e.g. vagal pathways).
These experiments showed that CCK-8 and CCK-58 produce very similar 
Ca2+ signalling, mitochondrial metabolism and ZG secretion in murine 
PACs and that very similar responses were seen when repeated in human 
isolated? ACs.
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AB
Figure 3.1: Secretion in isolated murine PACs responding to Ach stimulation A) 
Taken from Belan et al. (1996) this graph shows typical loss of fluorescence in 
zymogen granules (ZG) loaded with quinacrine and stimulated with Ach. The drop 
was approximately 10 per cent of baseline. B) Figure from Myoung et al. (2004), 
which shows quinacrine loading of zymogen granules. Individual ZG show a drop 
in fluorescence when stimulated of approximately 10 per cent from baseline. This is 
an indication of secretion from the PACs.
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3.2 Materials and methods
3.2.1 Isolation of murine and human PACs
Murine PACs were isolated as previously described in Methods Chapter. 
Human PACs were obtained from 14 patients (median age 59yrs; 
interquartile range 57-68yrs) undergoing surgery between January 2004 and 
February 2008 (See table 3.1). It was discovered that it was necessary to be 
selective with the patients, and only take samples from patients whose 
underlying disease induced no pancreatic or biliary duct obstruction. 
Preliminary work with human PACs, from patients undergoing surgery for 
pancreatic cancer, showed poor morphology and poor responses to 
secretagogues. Such patients frequently had disease-related obstruction of 
the pancreatic and/or biliary ductal system. However when patients with 
unobstructed pancreatic disease had tissue sampled, human PACs with 
excellent morphology were obtained. As a result many patients donating 
tissue reported here underwent surgery involving the left side of the 
pancreas, and had no obstruction of the main pancreatic duct. Interestingly 
the poor morphological PACs obtained from obstructed disease looked very 
similar to images of isolated human PACs in publications, which recorded 
no response to CCK stimulation (Ji et ah, 2001). This strongly suggests that 
previous work by other groups had been undertaken with suboptimal cells.
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3.2.2 Solution and chemicals
Extracellular solution contained (mM): NaCl 140, KC1 4.7, MgCk 1.13, 
CaCb 1, D-glucose 10, HEPES 10, adjusted to pH 7.35. As described in 
methods chapter protease inhibitor tablet (1 tablet, Roche, Germany) and 
benzamidine (ImM, Sigma-Aldrich) were added to human PACs 
extracellular solution to reduce spontaneous zymogen activation. Pyruvate, 
a substrate for mitochondrial metabolism was added to keep cells in optimal 
condition (100pm). CCK-8 and CCK-58 were added to extracellular 
solution to make physiological preparations (2pM and lOpM) and supra­
maximal preparations (lOnM). Human synthetic CCK-58 was supplied by 
UCLA peptide synthesis facility (Dr J.R. Reeve), and was synthesized using 
an Applied Biosystems Peptide Synthesizer (Foster City, CA), unblocked 
and purified to >90 per cent (Reeve et ah, 2004).
Atropine (1 pM) was added to extracellular solutions, as it prevents 
activation muscarinic receptors and responses to Ach, but not to CCK 
(Petersen, 1992). Tetrodotoxin (100 nM) blocks voltage-gated Na= channels 
and other potential neuro-transmitters.
Fluo 4-AM (3pM) was loaded into murine cells by incubating for 30 
minutes at 37°C and used to measure changes [Ca2+]i. Fluorescence was
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excited by an argon 488 nm laser and emission collected between 505-550
nm.
Mitochondrial metabolism was assessed simultaneously by monitoring 
NADH autofluorescence in the perigranular mitochondrial belt (excitation 
363 nm; emission 390-450 nm).
Quinacrine (lOpM) was loaded into murine and human PACs by incubating 
for 10 minutes at 37°C, then washing out. Confocal imaging of cells loaded 
with fluorescent quinacrine was performed using a Zeiss LSM510 system 
(Carl Zeiss, Germany). Excitation was at 488nm; emission >505 nm.
Images were composed of 256x256 pixels, and optical sections were 5-6jum. 
Image analysis was undertaken with LSM510 software.
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3.3 Isolated murine PACs responses to CCK-8 and CCK-58 
3.3.1 Effects of CCK-8 and CCK-58 on [Ca2+]i and mitochondrial 
stimulus-metabolic coupling in isolated murine pancreatic acinar cells
Stimulation of isolated murine PACs with physiological levels of CCK-58 
(10 pM) produced typical oscillatory, focal spikes of [Ca2+]j starting in the 
apical, granular region and spreading basally (12 out of 15 cells). These 
were very similar to those typically seen in response to CCK-8 stimulation 
(see figure 3.2).
Hyperstimulation with supra-maximal doses of CCK-58 (5-10 nM) led to a 
single large spike in [Ca2+]i, that subsequently declined to an elevated 
baseline (10 out of 10 cells). Removal of Ca from the extracellular 
solution, and addition of Ca2+ chelator ethylene glycol tetra-acetic acid 
(EGTA), led to a fall in [Ca2+]j back to baseline, and demonstrated that this 
toxic rise in [Ca2+]i was dependent on Ca2+ entry to the cell. Again these 
responses were practically identical to those seen in CCK-8 
hyperstimulation (see figure 3.3).
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9+Additionally each spike in [Ca ]j at physiological stimulation was 
associated with a rise of mitochondrial NAD(P)H autofluorescence in the 
perigranular region that denoted stimulus-metabolism coupling, generating 
ATP necessary for zymogen secretion (see figure 3.4).
10pM CCK-58
NAD(P)H
Time(s)
Figure 3.4: Representative trace showing stimulus-metabolic coupling
2+
induced by 10 pM CCK-58. After each elevation of [Ca |. a slower rise in 
NAD(P)H (red trace) was recorded. Similar responses were seen with CCK- 
8 in 6 cells. Reproduced with permission Dr D Cridddle (from Criddle et al., 
2009).
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3.3.2 Effects of CCK-8 and CCK-58 on secretion in isolated murine
PACs
Quinacrine loading of zymogen granules, and subsequent drop in 
fluorescence levels in response to CCk-8 and CCK-58 stimulation, was used 
to measure isolated murine PACs secretion. Quinacrine is an acidophilic 
fluorescent dye that is preferentially taken up by secretory granules and has 
been used to detect and quantify exocytosis in previous isolated cell work 
(Campos-Toimil et al., 2000)(Park et al., 2004). Typical quinacrine uptake 
staining was shown in figure 2.x (Materials and Methods Chapter).
The apical area of the PACs, containing quinacrine loaded ZGs, were 
selected (using the confocal imaging software) for continuous recording of 
fluorescence throughout the duration of the experiment. Separately the 
basolateral area was also selected, to give a baseline level for comparison. 
The basolateral area did not show significant quinacrine uptake. Figure 3.5 
shows typical representative traces from isolated murine PACs stimulated 
with physiological levels of CCK-8 (Figure 3.5A) and CCK-58 (figure 
3.5B). The fluorescence of the selected ZG containing apical area drops, 
representing loss of quinacrine (along with the rest of the contents of the 
ZGs) during secretion. It was observed that no changes occurred in the
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basolateral area during this process, indicating quinacrine was being lost 
from the PACs, into the lumen. This process was repeated in multiple 
isolated murine PACs, over several different experiments and on different 
days. The mean results were (see figure 3.6A & B). The loss of quinacrine 
fluorescence from apical regions in response to physiological CCK-8 or 
CCK-58 was very similar with no significant difference between CCK-8 
2pM (n=13), CCK-8 10 pM (n=ll) or CCK-58 (n=16). In each case the 
drop was about a third from the initial level.
There was no significant quinacrine secretion when cells were 
hyperstimulated with supra-maximal levels of CCK-8 or CCK-58 (10-20 
nM). Indeed continuous perfusion with supra-maximal CCK-8 or CCK-58 
over a period of about 20minutes, led to PACs damage, with evidence of 
membrane breakdown.
These experiments demonstrate that CCK-8 and CCK-58 have very similar 
effects on isolated murine PACs secretion in vitro.
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Figure 3.5: Representative traces of apical quinacrine loss from isolated 
murine PACs by secretion in response to physiological (A) CCK-8 and (B) 
CCK-58. The inset image in both diagrams shows acinar cells loaded with 
quinacrine and selection of regions for analysis during CCK stimulation 
(green for apical; black for basolateral). On stimulation both demonstrated 
a decrease in fluorescence of about a third. In both figures arbitrary units 
of fluorescence were applied. B reproduced with permission from Dr D 
Criddle.
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Figure 3.6: Meaned quinacrine fluorescence response to physiological 
CCK-8 and CCK-58. (A) shows meaned decrease in quinacrine 
fluorescence in apical regions of isolated murine PACs in response to 
CCK-8 2 pM (number of cells (n) = 13). (B) Shows overlayed apical 
quinacrine responses in isolated murine PACs to CCK-58 (n = 16) and 
CCK-8 (n=l 1) both at 10 pM. The responses are virtually identical. In 
all groups drop in fluorscence was apporximately a third. 
Fluorescence normalised from baseline (F/F0). Both figures show 
standard error bars. B reproduced with persmission from Dr D 
Criddle.
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3.4 Isolated human PACs responses to CCK-8 and CCK-58
3.4.1 Effects of CCK-8 and CCK-58 on [Ca2+]i and mitochondrial 
stimulus-metabolic coupling in isolated human pancreatic acinar cells
Working within a collaboration our group showed that stimulation of 
isolated humans PACs with physiological (2-20 pM) CCK-8 (63 cells in 
total) or CCK-58 (19 cells) led to clear spikes of [Ca2+]i, that included 
oscillatory responses. To ensure only CCK responses were recorded, 
atropine (1 pM) and atropine with tetrodotoxin (100 nM) were included in 
extracellular solutions (see figure 3.7). The spikes of [Ca2+]i in response to 
CCK-8 or CCK-58 were not inhibited, demonstrating that their effects were 
not due to ACh or other neurotransmitter.
The [Ca2+]j spikes demonstrated apical to basolateral progression and a 
simultaneous rise in NADH autofluorescence (indicating stimulus-metabolic 
response). Again this is in keeping with the well-established murine model. 
There were no significant differences between CCK-8 and CCK-58 in type 
or scale of [Ca2+]i oscillatory spikes.
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Figure 3.7: Effects of physiological (2-20 pM) CCK-8 (A) and CCK-58 (B)
2+
on cytosolic calcium concentration, [Ca |. in isolated human pancreatic
acinar cells. A cluster of human FACs in shown in inset image in (A), which
2+
also shows the typical oscillatory spikes in |Ca ]. in response to stimulation.
2+
(A) additionally demonstrates caffeine application reversibly inhibits Ca 
signalling. F/F( represents ratio of change in fluorescence from baseline (F0) 
at given time point (F).
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These oscillatory [Ca2’ ]i spikes could be reversibly inhibited with caffeine. 
When physiological levels (2-20 pM) of both CCK-8 (15 cells) and CCK-58 
(11 cells) were added to extracellular solutions, reversible inhibition of 
stimulation was elicited by caffeine (5 mM). Caffeine is a membrane- 
permeable inhibitor of IP3R and is known to inhibit both ACh and CCK 
stimulated Ca release, by acting as a reversible antagonist to Ca 
releasing-IP3R channels on the endoplasmic reticulum (Griddle et ah, 
2006)(Petersen et al., 2008). Ceasing caffeine stimulation led to prompt 
return of [Ca2+]i spikes (see figure 3.7A).
Hyperstimulation with supra-maximal levels of CCK-8 (5-10 nM) led to
1
single spikes in [Ca ]i with an elevated baseline, again as also seen in 
isolated murine PACs (see figure 3.8). These elevations returned to baseline 
when the stimulus was stopped.
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Figure 3.8: Effects of hyperstimulation with CCK-8 on [Ca |. in isolated 
human PACs. Supra-maximal levels of CCK-8 (5 nM) were applied to 
human PACs, in the presence of atropine and tetrodotoxin. 
Hyperstimulation produced an elevation, which remained at an elevated 
plateau until hyperstimulation ceased, when levels returned to baseline. 
F/Fo represents ratio of change in fluorescence from baseline (F0) at given 
time point (F).
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3.4.2 Effects of CCK-8 on secretion from isolated human PACs
As in the murine isolated PACs experiments detailed above, Quinacrine 
loading of zymogen granules, and subsequent drop in fluorescence levels in 
response to CCk-8 and CCK-58 stimulation, was used to measure isolated 
human PACs secretion. Due to the controversy regarding direct CCK 
stimulation of human PACs, steps were taken to inhibit possible responses 
to other residual neurotransmitters and/or nerve endings. These measures 
included adding tetrodotoxin (100 nM) and atropine (1 pM) to all 
extracellular solutions, so that responses to CCK stimulation could be 
shown to be from direct activation of CCK receptors.
Figure 3.9A shows a representative trace of quinacrine and NADH 
fluorescence in response to physiological CCK-8 (10 pM), from one human 
PAC. Quinacrine shows a similar drop in fluorescence in human as in 
murine PACs. In all cases the loss is approximately 20 per cent from initial 
levels. There is simultaneous evidence of stimulus-metabolic coupling, 
shown by a rise in NADH autofluorescence, showing this is active 
secretion. Figure 3.9B shows the meaned results from 7 separate human 
PACs, again demonstrating an approximate loss of fluorescence of 20 per 
cent.
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Figure 3.9: Apical quinacrine secretion in response to physiological CCK-8 <10 
pM) in isolated human FACs. A) Representative apical quinacrine trace, and 
simultaneous NADH recordings, in human PAC when stimulated with 10 pM 
CCK-8, in the presence of atropine and tetrodotoxin. Inset image shows cluster of 
human FACs from which trace was taken. Note F/F0 for quinacrine is on the right 
y-axis. and that for NADH on the left y*axis B) Meaned apical quinacrine loss 
from 7 separate isolated human FACs (Mean values ± S.E. bars).
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3.5 Discussion
3.5.1 Isolated murine PACs responses to CCK-8 and CCK-58
The experiments undertaken with isolated murine PACs demonstrated 
markedly similar responses from CCK-8 and CCK-58. At physiological 
concentrations (1-20 pM) CCK-58 induced oscilatory [Ca2+]i spikes, which 
were generated at the apical pole and spread basolaterally. Such responses 
are typical of rodent and murine iolsated PACs with CCK-8 (Maruyama et 
ah, 1993)(Petersen and Tepikin, 2008). [Ca2+]j spikes were associated with 
metabolic activity of peri-granular mitochondria, with uptake of Ca2+ 
leading to stimulation of Ca2+-dependent dehydrogenase enzymes that 
generate NADH and ATP. This was detected by NAD(P)H 
autofluorescence. The consequence of this stimulus-metabolic couplong was 
zymogen granules secretion. This was detected by the drop in measured 
fluorescence of quinacrine-loaded ZGs. Again there was no difference 
between CCK-8 and CCK-58 stimulated cells. Our group also observed 
exocytotic activity by measuring amylase secretion during stimulation, 
which was also increased (Mmphy et al., 2008).
Hyperstimulation of isolated murine PACs with CCK-8/caerulein is a well- 
described model of experimental in vitro acute pancreatitis. Suprisingly
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recent work had shown CCK-58 did not induce pancreatitis in vivo 
experimental models (Yamamoto et aL 2007). However in our in vitro 
experiments CCK-58 and CCK-8 produced near-identical responses when 
isolated murine PACs were hyperstimulated (5-20 nM). Both peptides 
elicited typical elevations of [Ca2+ji with subsequent evidence of PACs 
damage. Our group measured several parameters of PACs damage not 
included in the results section (but presented in the groups publication: 
Murphy et al., 2008). These parameters include: trypsinogen activation 
detected using dye BZiPAR; increased proportion of necrotic cells after 
hyperstimulation with both CCK-8 and CCK-58; and morphological 
changes associated with pancreatitis, such as membrane blebbing and 
breakdown. The differences between in vivo and in vitro responses to CCK- 
58 may represent alternate pathways of action for CCK-58 in the whole 
animal, that aren’t available in isolated cell work.
Otherwise these experiments showed remarkedly similar effects for CCK-8 
and CCK-58 on isolated murine cells.
142
3.5.2 Isolated human PACs responses to CCK-8 and CCK-58
The experiments described with human isolated PACs demonstrated, for the 
first time, that physiological concentration of CCK-8 and CCK-58 elicit 
[Ca2+]i spikes, mitochondrial activation and secretion. The concentrations of 
CCK-8 and CCK-58 were equivalent to to that in vivo (Walsh, 1987), and 
elicited [Ca ]i spikes that were oscillatory and spread from apical to 
basolateral regions. These [Ca2+]i signals were linked to activation of 
mitochondrial metabolism, providing the ATP needed for secretion of 
zymogen granules from the apices. These findings are very similar to those 
previously reported in murine and rodent isolated PACs (Petersen et al, 
2008). There is debate as to which form of CCK is the most physiologically 
active, as CCK-58 has been found to be the most dominant circulating form 
in several species (Sun et ah, 1992)(Reeves et al., 2003). All CCK subtypes 
share the same C-terminal hepapeptide amide sequence, that is necessary for 
binding to CCK receptor (Dufresne et al., 2006). These experiments found 
that effects of physiological concentrations of CCK-8 and CCK-58 had very 
similar effects on isolated human PACs.
The effects off CCK-8 and CCK-58 were conclusively not produced by Ach 
mediaited action, as suggested by other groups (Ji et al., 2001)(Owyang et
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al., 2004)> as the responses ocurred in the presence of atropine and 
tetrodotoxin. However as this work was in isolated human PACs in vitro, it 
is not possible to say if CCK also activates vagal pathways separately in 
vivo.
The selection of human tissue from donors with unobstructed pancreatic 
disease, which results in less pancreatic fibrosis and damage, and sussequent 
rapid transport to the lab (in optimised extracellular solution) was 
demonstrated to be critical in obtaining viable human PACs for 
experimental in vivo work. Preliminary work with tissue from obstructed 
disease showed PACs were morphologically poor and responses were poor. 
Our group has postulated that the failure of other groups (Ji et al., 2001) to 
obtain CCK responses was due to not optimising the cells and using poor 
quality human PACs.
Caffeine works by reversibly inhibiting IP3R channels, which are found on 
the endoplasmic reticulum and on the membranes of zymogen granules. By 
showing that caffeine reversibly inhibits response of human PACs to CCK 
stimulus it is seen that human PACs have mechanisms in common with 
murine PACs. This action suggests a possible thearpeutic role for caffeine, 
which needs further exploration.
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Finally, by demonstrating such similarity between murine and human PACs 
mechanisms, the argument for the continued use of CCK/caerulein 
experimental animal models is strengthened, and translating findings in 
these models to human disease becomes more valid.
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CHAPTER 4
Effects of BAK, Bcl-2 and BAX knock-out on 
murine caerulein-induced in vivo experimental
pancreatitis
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4.1 Introduction
Members of the Bcl-2 family of proteins regulate cell death pathways, and 
the balance between apoptosis and necrosis is thought to be critical in 
determining the severity of pancreatitis (Bhatia, 2004)(Pandol et ah, 
2007)(Golstein and Kroemer, 2007).
Previous work has suggested that Bak and Bax are pro-apoptotic (Bhatia, 
2004)(Kroemer et ah, 2007)(Chipuk et al., 2008) and have a protective role 
in pancreatitis. Both are involved in cytochrome c release from 
mitochondria, by formation of the mitochondrial outer membrane pore 
(MOMP) and by action on opening of the mitochondrial permeability 
transition pore (MPTP. It postulated that by knock-out of these genes there 
should be less apoptotic activity and cell death pathways would shift to 
necrosis with an increase in severity of pancreatitis.
By contrast Bcl-2 has been suggested as pro-survival (or anti-apoptotic) in 
its action, stopping the formation of the MOMP and inhibition of 
cytochrome c (Bhatia, 2004)(Gukovsky et ah, 2011). However it may also 
have a role in regulating necrosis directly, and not indirectly just by 
negative actions on apoptosis (Sung KF et ah, 2009). In in vitro models of 
cholecystokinin-induced pancreatitis it was shown that inhibiting Bcl-2 (and
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Bcl-xL) increases loss of A^m (mitochondrial membrane potential) and 
facilitates necrosis, whilst also inhibiting CCK-induced caspase-3 activation 
and apoptosis. The net result was increase in necrosis and severity. This 
makes Bcl-2’s role more ambiguous.
There is wide acceptance that knowledge surrounding the interactions of 
these proteins is far from complete. The current sub-divisions into ‘anti- 
apoptotic’ and ‘pro-apoptotic’ may be too simplistic. Despite their 
importance in elucidating cellular mechanism in pancreatitis, in vitro work 
may not translate to living organism. Further investigation of the actions of 
these important proteins in vivo, using experimental models of acute 
pancreatitis, has not been reported before and is important to help further 
explore the mechanisms involved in severity. This chapter details 
experiments investigating the role of Bcl-2, Bak and Bax genes in 
determining the severity of caerulein-induced murine experimental in in 
vivo acute pancreatitis.
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4.2 Methods
Acute pancreatitis was induced in mice by means of the standard caerulein- 
induced model, in which 7 hourly intra-peritoneal (IP) injections of 
caerulein 50 pg/kg were administered. End points for the experiments were 
8, 12 and 24 hours after the first injection. C57BL/6 male mice (aged 8-12 
weeks) were used as the controls for the Bak knock-out (KO) mice and for 
the Bcl-2 and BAX groups their own wild types (WT) were used as 
controls. Each experimental group contained 6 animals (unless otherwise 
stated). Buprenorphine analgesia was administered IP with the first dose of 
caerulein.
The development of acute pancreatitis was evaluated by measurement of 
pancreatic oedema (pancreatic wet-to-dry weight ratio), serum amylase, 
grading of H&E stained histology slides and scoring of slides stained by 
immunohistochemistry (IHC) for caspase-3 (a measure of apoptotic activity) 
(as detailed in Chapter 2 - Methods).
Initial work was undertaken on the C57BL/6 animals, to ensure the model 
produced expected results in the control group. Pancreatic oedema and 
serum amylase measurements were typical (see figure 4.1).
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Figure 4.1: Caerulein-induced acute pancreatitis in C57BL/6 mice with 
measurements at 8, 12 and 24 hrs. (A) Shows mean scores for pancreatic 
oedema. Progression over time points typical (except 24 hr lower than 
expected). (B) Shows progression of serum amylase as expected. All groups 
contained 6-8 animals. Figures show mean values with SEM bars.
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Histopathological scoring was undertaken by two blinded assessors, who 
simultaneously (but without communication) scored 10 fields per slide. The 
mean score over the ten fields for each assessor was combined into a total 
mean score per slide. Mean scores for assessors were very similar and 
showed no significant difference (see figure 4.2a). The combined scores 
demonstrated typical progression over the time periods the reach at 
maximum at 24 hours (see figure 4.2b).
7 hourly IP injections of Caerulein induced typical histopathological 
changes, which progress with time up to 24 hours. At eight hours, early 
oedema, perivascular inflammatory cell recruitment and occasional, focal 
necrosis were observed (figure 4.3c). At 12 hours oedema was maximal and 
there was moderate inflammatory infiltration of pancreas tissue, with 
increasing necrosis. By 24 hours there was extensive inflammatory cell 
infiltration and marked areas of necrosis (see figure 4.3e&f).
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Figure 4.2: Caerulein-induced acute pancreatitis in C57BL/6 mice with 
measurements at 8, 12 and 24 hrs. (A) Shows comparison between mean 
scores for each assessor (no significant difference). (B) Shows total mean 
scores over the time points. All groups contained 6-8 animals. Figures show 
mean values with SEIM bars.
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Figure 4.3: Typical appearance of C57BL/6 murine pancreas after 7 hourly IP 
injections of caerulein (or saline in controls). (A)&(B) Show normal appearances 
of pancreatic tissue. (C) Shows typical appearances at 8hrs with some oedema 
and focal necrosis. (D) Shows enlarged boxed area from (C) - with focal necrosis 
arrowed. (E) Shows severe changes after 24 hr, with extensive inflammatory cell 
infiltrate and necrosis (F) Shows enlarged boxed area from (E). Magnification 
xlOO (except B & F at Magnification x200).
Caspase-3 is an upstream protease in both the extrinsic and intrinsic 
apoptotic pathways. As such activation of caspase-3 is a key point in 
apoptosis, and measurement of caspase-3 is widely used to quantify 
apoptotic activity in other organs (Przemeck et al., 2007). Caspase-3 was 
stained by IHC in pancreas tissue and the slides subsequently scored using 
ImageJ software, and results expressed as a ratio of caspase-3 staining cells 
to normal cells. Typical capase-3 IHC staining of murine pancreas tissue is 
shown in figure 4.4. In C57BL/6 mice there were no appreciable levels of 
apoptotic activity until 12-24 hours.
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Figure 4.4: Representative images of caspase-3 IHC staining in 
murine acute pancreatitis. Time points are: A. Ohr; B. 8hr; C 24hr. 
Caspase-3 stains brown ,and is most obvious in C. (Magnification x 
200).
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4.3 Bak knock-out in murine experimental pancreatitis
Acute pancreatitis was induced in Bak knock-out (KO) mice by means of 
the standard caerulein-induced model. End points for the experiments were 
8, 12 and 24 hours after the first injection. Each time group contained 6-8 
animals and one group had sham injections of saline only. Results for Bak 
KO were compared against C57bL/6 (the wild-type for Bak KO).
Bak KO mice showed significantly lower pancreatic wet-to-dry weight ratio 
at 12 hours, but not at other time points. Both C57BL/6 and Bak KO mice 
showed lower ratios at 24 hours, which was contra to expectations, as 
oedema should be maximal at 24 hours (See figure 4.5a).
Serum amylase was significantly lower in the Bak KO group at 12 hours 
compared to the C57BL/6 group. Other time points showed no significant 
difference, although the 8 hours group did show a higher mean value in the 
Bak KO group (see figure 4.5b).
The histopathological score was lower in the Bak KO group at all three 
experimental time points (see figure 4.6). These results provide evidence 
that Bak KO is protective in caerulein-induced murine experimental 
pancreatitis.
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Figure 4.5: Comparing pancreatic oedema (A) and serum amylase (B) in 
caerulein-induced pancreatitis in Bak knock-out (red) and C57BL/6 (blue) 
mice. * significant difference at <0.05 level. Mean values ± SEM.
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Figure 4.6: Difference in pancreatitis histopathological score between 
C57BL/6 (blue) and Bak -/- mice (red) at 8, 12 and 24 hr (with a saline 
group at 8hr). Standard mean values ± SEM.
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4.4 Bcl-2 knock-out in murine experimental pancreatitis
Acute pancreatitis was induced in Bcl-2 knock-out (KO) mice by means of 
the standard caerulein-induced model. End points for the experiments were 
8, 12 and 24 hours after the first injection. Each time group contained 6 
animals and one group had sham injections of saline only. Results for Bcl-2 
KO were compared against wild-type (WT - control group).
Bcl-2 KO are much smaller and weaker than WT. Approximately half die 
before 6 weeks (Nakayama et al., 1994). Abnormalities include: small ears; 
greying of fur at 4 weeks; low lymphocyte count; polycystic kidney disease. 
As a consequence it was harder to breed viable adults. Due to cost, and 
time, constraints the 24 hours time group only contained two animals, so 
conclusion from this group have to be treated with caution.
There was no significant difference in pancreatic wet-to-dry weight ratio 
between the Bcl-2 KO and the WT controls. Even so there was trend 
towards a higher pancreatic wet-to-dry weight ratio in the Bcl-2 KO group 
at 12 hours and 24 hours (see figure 4.7a).
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Serum amylase was significantly higher in the Bcl-2 KO group at 12 hours 
compared to the WT group. This was also the case at 24 hours, though this 
group only contained 2 animals (see figure 4.7b).
Over 24 hours the histopathological score showed no clear difference 
between the groups. At early stages (8 hours) the Bcl-2 KO group 
histopathological score was lower than the WT group, and when the 
breakdown of the score was analysed this was due to a lower inflammatory 
and necrosis score in the Bcl-2 group. It should be noted, however, that the 
score in the WT group is still relatively low (2.03 out of 9.0), and in the 
early stages small differences can lead to large differences between groups. 
If this finding is correct then it suggests Bcl-2 KO are slower to develop an 
inflammatory response than wild types, yet by 12-24 hours this has made no 
difference to the severity of pancreatitis.
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Figure 4.7: Comparing pancreatic oedema (A) and serum amylase (B) in 
caerulein-induced pancreatitis in Bcl-2 knock-out (red) and wild type 
(WT) (blue) mice. * significant difference at <0.05 level. 24 hours Bcl-2 
group contained only 2 animals. Mean values ± SEM.
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Figure 4.8: Difference in pancreatitis histopathological score between 
WT (blue) and Bcl-2 -/- mice (red) at 8, 12 and 24 hr (with a saline 
group also at 8hr). Only 2 animals in the 24 hr group.
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4.5 Bax knock-out in murine experimental pancreatitis
Acute pancreatitis was induced in Bax knock-out (KO) mice by means of 
the standard caerulein-induced model. End points for the experiments were 
8, 12 and 24 hours after the first injection. Each time group contained 6-8 
animals and one group (8 hours) had sham injections of saline only. Results 
for Bax KO (Bak -/-) were compared against wild-type (Bax +/+).
There was no significant difference in pancreatic wet-to-dry weight ratio 
between the Bax KO and the WT controls (see figure 4.9a).
Serum amylase in the Bax KO group, compared to WT controls, was 
significantly higher at 12 hours, but was otherwise very similar at other time 
points (see figure 4.9b).
Bax KO mice showed evidence of a more severe early stage of pancreatitis 
compared to WT controls (see figure 4.10). At both 8 and 2 hour’s the 
overall severity score was higher in the Bax KO groups. By 24 hours the 
control group’s score had reached similar levels. The breakdown of the 
scores in shown in figure 4.11(A,B,C). Bax KO have overall higher oedema, 
inflammatory infiltrate and (interestingly) even necrosis at a much earlier 
stage than WT controls.
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Figure 4.9: Comparing pancreatic oedema (A) and serum amylase (B) in 
caerulein-induced pancreatitis in Bax knock-out (red) and wild type 
(WT) (blue) mice. * significant difference at <0.05 level. Mean values ± 
SEM.
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Figure 4.10: Difference in pancreatitis histopathological score between 
WT (blue) and Bax -/- mice (red) at 8, 12 and 24 hr (with a saline 
group also at 8hr) (4-6 animals per group). Mean values ± SEM.
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Figure 4.11: Breakdown of histopathological score in caerulein- 
induced AP in Bax knock-out (red) mice compared to WT controls 
(blue) at 8, 12 and 24 hours. Bax KO demonstrate higher oedema (A) 
and inflammation (B) scores in the first 12 hours, but by 24 hours 
levels are similar to controls. 4-6 animals per group. Mean values per 
group ± SEM.
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Figure 4.11C: Breakdown of histopathological score in caerulein- 
induced AP in Bax knock-out (red) mice compared to WT controls 
(blue) at 8, 12 and 24 hours. Bax KO demonstrate higher levels of 
necrosis from a much earlier time points than controls, but by 24 
hours levels are similar in both groups. 4-6 animals per group. Mean 
values per group ± SEM.
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The WT groups showed a steadier increase of severity over the time points 
(similar to the C57BL/6 groups from the previous section) and by 24 hours 
had reached the same level of severity as the Bax KO group.
This difference is interesting and suggests Bax KO increases the potential 
for pancreatic acinar cells injury in hypersensitivity-induced pancreatitis, 
which is the hypothesis to be tested. However the hypothesis also stated that 
this would be due to decreased apoptosis and increased necrosis, yet in the 
next section it will be described how apoptosis appeared to increase in 
caerulein-induced pancreatitis in Bax KO mice.
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4.6 Caspase-3 staining and evidence of apoptosis in caerulein 
induced pancreatitis in Bak KO and Bax KO mice
All three knock-out mice (Bak KO, Bcl-2 KO and Bax KO) had pancreatitic 
tissue removed for caspase-3 immunohistochemistry (IHC) following 
induction of caerulein-induced pancreatitis as already described. Tissue was 
taken at 8, 12 and 24 hours time points and fixed on slides for assessing 
after IHC staining. Each slides had 5 representative fields at of view 
digitally imaged (x 200). The images were then processed using Image! 
software to obtain a ratio for caspase-3 stained-to-normal cells. The five 
fields were meaned to give a ratio per slide. Each animal group contained 4- 
6 animals (except the Bcl-2 KO 24 hr group, which only contained 2 
animals) and the total mean value per group was calculated (see figure 5.2). 
The Bcl-2 KO groups’ results were very similar to the C57BL/6 and Bak 
KO. Because of this, and because the 24 hours group was too small to be 
included, the Bcl-2 KO group has not been shown in the figure.
There was very little caspase-3 activity, in any group, until 12 hours. 
C57BL/6, Bak KO, and Bcl-2 KO all showed very similar levels of caspase- 
3 activity, which increased slightly over the 24 hours. Bcl-2 KO appeared to 
have no effect on apoptosis, as measured by caspase-3 activity, and had
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Figure 4.12: Caspase 3 IHC staining. C57BL/6 (blue), Bak Null (red) and 
Bax Null (green) mice are compared at 8, 12 and 24 hours after induction of 
caerulein-induced acute pancreatitis in. The y-axis is caspase-3 IHC stained 
cells (calculated as the ratio of stained cells to normal cells per field of view 
at x200 magnification). 5 fields of view per animal are combined for an 
overall mean, and there were 4-6 animals per group. Values presented are 
mean group values ± SEM.
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already demonstrated no difference in histopathological severity from WT 
controls. Although Bak KO had less severe histopathological severity from 
controls at all time points, there was no evidence this was related to 
apoptotic activity, as caspase-3 activity was the same as controls.
Bax KO showed significantly elevated caspse-3 activity compared to the 
other groups. This was a surprising result. The histopathological severity 
was much greater in Bax KO than in controls, and it was expected that 
apoptosis (and thus caspase-3 activity) would be decreased. Bax is 
considered pro-apoptotic and to find an increase in apoptosis, with more 
severe pancreatitis, was unexpected and suggests the role of Bax in cell 
death pathways is more complicated than previously thought.
Figure 4.13 shows representative slides of C57BL/6, Bak KO and Bax KO 
at 8, 12 and 24 hours.
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Figure 4.13: Representative slides stained by IHC for caspase-3 from C57B1/6 
(left column), Bak Null (middle column) and Bax Null (right column) mice. All 
slides show pancreas specimens after induction of caerulein experimental acute 
pancreatitis. Experiment time points were 8 hr (top row), 12 hrs (middle row) and 
24 hrs (bottom row). Caspase-3 stains brown and increased activity can be seen in 
Bax Null at 12 an 24 hrs. Light microscope magnification x200.
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4.7 Discussion of caerulein-induced acute pancreatitis in Bak, Bax 
and Bcl-2 murine knock-outs
The Bcl-2 family proteins have been shown to have important roles 
regulating cell death pathways, and are thought to be through interactions 
with mitochondria (Bhatia, 2004). Bak and Bax are thought to be important 
in facilitating cytochrome c release from mitochondria, through formation 
of mitochondrial OMM pores (Gukovsky et ak, 2011), and thus are 
important to the intrinsic apoptotic pathway. Until recently their activity 
was thought to be purely ‘pro-apoptotic’ yet there their full mechanisms of 
action are still unclear. If their actions are purely pro-apoptotic, then 
pancreatitis in Bak and Bax KO mice should lead to reduced apoptosis and 
more severe pancreatitis. The previous results showed that the 
histopathology of Bax KO was indeed more severe than WT controls in the 
first 12 hours of pancreatitis, though severity was similar at 24 hours. 
However Bak KO showed less severe histopathology at all times points, 
against C57BL/6 controls. These results suggest a few points in the context 
of caerulein murine AP: i) that loss of Bak is protective; ii) that loss of Bak 
does not appeal' to influence apoptosis; iii) that loss of Bax is detrimental; 
iv) that loss of Bax leads to increased apoptosis and necrosis in the early 
stages. These results suggest that the current understanding of the roles of
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Bak and Bax may be simplistic and there are more complex interactions 
occurring. In particular Bax interactions are suggested to be more important 
than Bak in preventing severe disease. Also apoptosis per se may not 
always be protective in AP.
Bcl-2 is considered as ‘anti-apoptotic’ (Bhatia. 2004)(Pandol et al., 
2007)(Gukovsky et al., 2011) and loss, through knock-out, was expected to 
be protective in caemlein murine AP. However Bcl-2 KO did not 
demonstrate either a change in severity of AP or a change in apoptotic 
activity from wild types. This may fit with recent evidence that the role of 
Bcl-2 is not just simply ‘anti-apoptotic’ and its effect may depend on the 
balance of a number of different interactions (e.g. cytochrome c inhibition; 
effecting mitochondrial ATP production). It should be noted that, due to 
difficulty in breeding these frail animals, some Bcl-2 KO groups had less 
than optimal numbers from which to draw results.
These experiments measured parameters of pancreas damage during 
caerulein-induced murine AP. In these experiments pancreatic wet-to-dry 
weight ratio was not found to be an accurate way of measuring pancreatic 
oedema. Serum amylase levels were useful to confirm pancreatitis, but did 
not always accurately reflect severity. Histopathological score was the most
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useful parameter and caspase-3 IHC staining gave useful insight into 
apoptotic activity.
These experiments could be improved by using other parameters of 
pancreatic injury and also of concurrent systemic injury. Attempts were 
made to measure pancreatic trypsin activity and lung histopathology, but for 
technical reasons were unsuccessful.
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Chapter 5
Actions of caffeine in murine caerulein-induced 
in vivo experimental pancreatitis
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5.1 Introduction
Caffeine has been shown to reversibly inhibit Ca2+ signalling in isolated 
murine PACs, by inhibition of IP3R channels (Petersen and Sutton, 
2006)(Criddle et al., 2007b), sited on endoplasmic reticulum and zymogen 
granule membranes (see Introduction chapter). It may also have other 
effects on cAMP recycling (Wu et al., 2009), inhibition of adenosine Al 
receptor (Fredholm et al., 1999)(Satoh et al., 2000) and inhibition of store- 
operated Ca channels (SOC). As detailed in results chapter 3, our group 
has shown that caffeine had similar inhibitory affects to physiological (1-20 
pM) CCK-8 and CCK-8 stimulation in isolated humans PACs. Caffeine is 
metabolised in the liver, by action of cytochrome P450, into several 
metabolites: paraxanthine, theobromine and theophylline. It is possible they 
too have potential therapeutic action in pancreatic acinar cells.
Caffeine therefore has potential as a therapeutic agent in acute pancreatitis. 
Caffeine is used as a therapeutic agent in some circumstances in humans. It 
is used to treat neonatal apnoea in premature infant, though the mechanisms 
of action are unclear (Erenberg et al., 2000), Caffeine stimulates increased 
breathing frequency (possibly through increasing the sensitivity of
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chemoreceptors to CO2), enabling premature infants to be weaned off 
ventilators quicker (Steer et al., 2004). The maintenance dose is 5-10 mg/kg.
Caffeine has been shown to have a half-life in murine models of 
approximately 1 hour (Bonati et al., 1984) and is lethal to mice at doses of 
100 mg/kg (Fredholm et al., 1999). This causes a concern as our group used 
doses of caffeine at a concentration of 2-5 mM (equivalent to 50-100 
mg/kg) in our isolated cells work. In preliminary work it was confirmed that 
100 mg/kg was lethal to mice and 50 mg/kg induced significant symptoms 
of caffeine toxicity (tremors, poor motor function and signs of distress). 
Concentrations of 1 mg/kg and 10 mg/kg were used, which produced no 
adverse side effects in mice, and were an equivalent to concentrations used 
in human neonatal disease.
5.2 Methods
A caerulein-induced murine experimental model of acute pancreatitis was 
used. Male C57BL/6 male mice (8-12 weeks old) were given 7 hourly IP 
injections of caerulein were given at a dose of 50 pg/kg and 8 hourly 
caffeine IP injections to achieve either 1 mg/kg or 10 mg/kg concentrations
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in vivo, was also administered via hourly IP injections, and as caffeine has a 
half-life of approximately 1 hour, it was necessary to calculate a loading 
dose and then subsequent hourly doses to maintain an average serum 
concentration. For an average concentration of 10 mg/kg: 13.5 mg/kg was 
given at 0 hours, followed by 7 hourly injections of 6.75 mg/kg to maintain 
an average concentration of 10 mg/kg (more precisely 10.125 mg/kg, these 
concentrations were chosen for ease of use)(see Table 5.1). Caffeine was 
made and stored (under sterile conditions) at a stock concentration of 2 
mg/ml. A reference chart was created to determine the volume of stock that 
would be needed per individual animal’s weight, to maintain a correct 
concentration of 10 mg/kg caffeine (see Table 5.2). The volumes required 
were appropriate for the size of the animals. Buprenorphine analgesia was 
administered IP with the first injection. Parameters measured included 
pancreatic wet-to-dry ratio, serum amylase, trypsin activity, 
histopathological scoring and caspase 3 IHC scoring.
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Experiment 
time point 
(hr)
IP caffeine 
injection cone 
(mg/kg)
Average circulating 
caffeine cone 
(mg/kg)
IP Caerulein cone 
(50 pg/kg)
0 13.5 10 50
1 6.75 10 50
2 6.75 10 50
3 6.75 10 50
4 6.75 10 50
5 6.75 10 50
6 6.75 10 50
7 6.75 10 -
8 End of experiment - pancreas harvested
Table 5.1 Protocol for timing and concentration of IP caffeine and caerulein. Shows 
doses required of IP caffeine to maintain an average concentration of 10 mg/kg. 
Caffeine was continued for an extra hour after caerulein had stopped, to maintain a 
circulating volume. In total 8 hourly IP injections of caffeine and 7 hourly IP of 
caerulein were given.
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Caffeine
Dose
(mg/kg)
Mouse
Weight
(kg)
Amount
required
(mg)
Caffeine 
Stock cone, 
(mg/ml)
Volume required 
(ml)
Initial injection
13.5
0.02 0.27 2 0.14
0.021 0.28 2 0.14
0.022 0.30 2 0.15
0.023 0.31 2 0.16
0.024 0.32 2 0.16
0.025 0.34 2 0.17
0.026 0.35 2 0.18
0.027 0.36 2 0.18
0.028 0.38 2 0.19
0.029 0.39 2 0.20
0.03 0.41 2 0.20
Subsequent injections
6.75
0.02 0,14 2 0.07
0.021 0.14 2 0.07
0.022 0.15 2 0.07
0.023 0.16 2 0.08
0.024 0.16 2 0.08
0.025 0.17 2 0.08
0.026 0.18 2 0.09
0.027 0.18 2 0.09
0.028 0.19 2 0.09
0.029 0.20 2 0.10
0.03 0.20 2 0.10
Table 5.2: Reference chart for calculating volume (ml) of caffeine stock (2 mg/ml) 
required for individual mice by weight (0.020 - 0.030 kg) to maintain an average 
serum caffeine concentration of 10 mg/kg. The initial injection is 13.5 mg/kg with 
subsequent doses of 6.75 mg/
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5.3 Effect of caffeine on severity of caerulein-induced murine 
pancreatitis
As described in Chapter 4, C57BL/6 mice were divided into groups (six 
animals) and received IP caerulein (50 pg/kg) injections hourly for 7 hours. 
They were sacrificed at 8 hours from the first injection. Caerulein induced 
acute pancreatitis (AP) by hyperstimulation, as evidenced by pancreatic 
oedema, rise in serum amylase, and histopathological changes including: 
vacuolisation, inflammatory cell infiltrate and necrosis. One group received 
sham injection with saline only, and showed no evidence of pancreatitis in 
the parameters measured.
In the interventional groups (again containing six C57BL/6 mice) caffeine 
was administered hourly, with caerulein. One group received 1 mg/kg and 
the other 10 mg/kg. Both groups were sacrificed at 8 hours and compared 
with the caerulein only groups. In addition two animals received 50 mg/kg 
caffeine, but toxic side effects were severe and this experimental group was 
not repeated. Although only representing these two animals, the results after 
50 mg/kg were interesting and some results are included in the figures.
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Compared to saline-only, caerulein administration caused a marked increase 
in pancreatic oedema (as measured by pancreatic wet-to-dry ratio) and 
serum amylase. Caffeine did not show a significant effect on these two 
parameters (see figure 5.1). Although the mean value of both pancreatic 
oedema and serum amylase was slightly lower in the 10 mg/kg compared to 
caerulein alone, these results were not significant. If the caffeine groups 
were taken alone, then in both categories caffeine 10 mg/kg showed less 
severe pancreatitis than caffeine 1 mg/kg.
Histopathology scoring revealed a difference when 10 mg/kg of caffeine 
was administered with caerulein compared to the caerulein-alone group (See 
figure 5.2). The mean total histopathological score for the 10 mg/kg group 
was 1.98 ± 0.26, while the caerulein-only group was 3.13 ± 0.52. In the 
breakdown of the score, 10 mg/kg showed markedly less histopathological 
evidence of oedema and inflammation than the caerulein-only group. There 
was no difference noted between the caffeine 1 mg/kg and caerulein-alone 
group, though of note was the finding of less histopathological evidence of 
oedema. Interestingly the caffeine 50 mg/kg group (though only two 
animals) showed a very low histopathological score, much lower than the 10 
mg/kg group.
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Figure 5.1: Effects of caffeine on pancreatic oedema (A) and serum amylase (B) in 
caerulein induced pancreatitis. All animals (6 per group) received 7 hourly 
injections of caerulein (blue), except saline controls (white). Treatment groups 
(red) received caffeine 1 or 10 mg/kg (red) (and two animals given 50 mg/kg). 
Animals were sacrificed at 8 hours (12 and 24 caerulein results included for 
comparison). Bars are mean values ± SEM.
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Figure 5.2: Effects of caffeine on histopathological features of caerulein 
induced pancreatitis. All animals (6 per group) received 7 hourly injections 
of caerulein (blue), except saline controls (white). Treatment groups (red) 
received caffeine 1 or 10 mg/kg (red) (and two animals given 50 mg/kg). 
Animals were sacrificed at 8 hours (12 and 24 caerulein results included for 
comparison). Graphs show overall histopathological score (top) and oedema 
component score (bottom). Bars are mean values ± SEM.
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Figure 5.2 continued: Effects of administering caffeine in caerulein- 
induced pancreatitis. Inflammation (top) and necrosis (bottom) 
component of histopathological scores shown. Bars are mean values ± 
SEM.
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5.4 Summary of effects of caffeine on severity in caerulein-induced 
murine pancreatitis
These results describe, for the first time, experiments investigating the 
potential protective effect of caffeine in in vivo caerulein-induced 
pancreatitis. Caffeine at a concentration of 1 mg/kg did not demonstrate any 
effects in reducing severity of acute pancreatitis in a caerulein-induced 
murine experimental model. However increasing the concentration of 
caffeine to 10 mg/kg showed a significantly lower histopathological score. 
Both these concentrations produced no evidence of toxic side-effects in live 
mice. There was a slighter lower pancreatic wet-to-dry weight ratio and 
serum amylase in the 10 mg/kg group, but these results were not statistically 
significant. Interestingly the pancreatic wet-to-dry weight ratio (as proxy for 
pancreatic oedema) showed no difference with 10 mg/kg caffeine, yet the 
oedema component of the histopathological score showed a marked 
decrease in mean value. It is difficult to reconcile these two results, but of 
all the parameters the histopathological score is usually taken as the ‘gold 
standard’ for severity assessment and carries more weight. It is more likely 
a reflection of the difficulty inherent in utilising the pancreatic wet-to-dry 
ratio parameter. It involves handling and measuring the weight of very small
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pieces of pancreas tissue. Very small errors in weighing and reweighing 
samples can produce widely vary results. As such the pancreatic wet-to-dry 
ratio should be treated with some caution, and the histopathological score 
given greater weight.
One potential criticism that could be levelled at the methodology is the 
administration of caffeine simultaneously with caerulein, as an hourly i.p. 
injection (albeit in separate syringes and separate i.p. sites). There is a small 
possibility caffeine interacts with caerulein directly within the murine 
peritoneal cavity, prior to absorption. In order to show this is not the case 
the experiments would need to be repeated with caffeine given a few hours 
after caerulein (i.e. at the mid-point of the experiment) to allow 
hypersecretion pancreatitis to begin and then demonstrate if caffeine can 
still ameliorate the disease.
The results for 50 mg/kg were included because of the dramatic effect this 
concentration showed in reduction of severity of caerulein-induced acute 
pancreatitis, as evidenced by the reduction of the histopathological score 
and (to a lesser extent) the amylase score. Even though caution must be 
employed in drawing conclusion from only two animals, these results show 
that increasing doses of caffeine seem to have a protective effect in
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caemlein-induced pancreatitis. However 50 mg/kg produced significant 
toxic side effects.
As previously described caffeine reduces Ca2+ signalling by reversibly 
inhibiting IP3R Ca channels (Petersen and Sutton, 2006) and inhibition of 
Ca2+ signalling is already a well established mechanism of reducing 
pancreatitis. It is of course entirely possible that other pathways are 
involved. Caffeine is known to reduce cyclic adenosine monophosphate 
(cAMP) by inhibiting one of the necessary activating enzymes, cAMP- 
phosphodiesterase (cAMP-PDE)(Wu et ah, 2009). cAMP is involved in the 
initiation of the inflammatory response. It has previously been shown that 
inhibiting cAMP-PDE by using specific inhibitors such as pentoxifylline 
(Chooklin et al., 2008)(Matheus et al., 2009)(De Campos et al., 2008) and 
rolipram (Sarmiento et al., 2010) reduces the severity of pancreatitis and 
caffeine could be working in a similar manner.
These initial results suggest a concentration of caffeine between 20-30 
mg/kg may produce protective effects without significant side effects. In 
addition the main metabolites of caffeine should be tested to determine if 
the protective mechanism is regulated by one of these specifically.
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CHAPTER 6
DISCUSSION
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6.1 DISCUSSION
6.1 The need for research in acute pancreatitis
The human disease of acute pancreatitis (AP) currently has limited therapy 
which can ameliorate or halt the progression of severe disease (Pandol et ah, 
2007). Severity of human AP is determined not only by localised pancreatic 
acinar cell (PAC) injury, but also by systemic effects, regulated by the 
systemic inflammatory response and potentially leading to multiple organ 
injury/failure. This systemic process takes time to develop, certainly over 
many hours, if not days, suggesting a potential therapeutic window for 
amelioration of the disease process. Indeed pancreatic necrosis, consistently 
associated with severe disease, is usually not present for the first 24-48 
hours after disease onset. There is still a great deal that is unknown during 
the initiation of PAC injury and so research has tended to focus on the 
response of PACs to injury and try to elucidate the cellular mechanisms 
involved in the hope of identifying therapeutic targets.
Multiple mammalian experimental in vivo and in vitro models have been 
develop to discover possible therapeutic targets. In particular is the 
extensive use of the murine experimental model, which in recent decades
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has allowed great advances in understanding of pancreatic acinar cell 
responses. Many different murine models have been developed to test 
specific hypotheses of disease initiation. These range from responses to 
toxic stimulation, to testing responses of genetic knockouts and transgenic 
models to examine the actions of specific components of cellular pathways. 
Many of these models seek to emulate an aspect of human disease; for 
example perfusion of pancreatic ducts with bile salts emulates conditions 
during gallstone pancreatitis (a common cause of human disease). Other 
models are less amenable to direct human correlation. One such example of 
a controversial model is the hyperstimulation model, typically utilising 
cholecystokinin or its analogue caerulein. Although this model is widely 
employed in research into AP, (and indeed has been employed in this body 
of work), there has been debate regarding its correlation to human disease. 
Chapter 3 of this thesis describes work undertaken to further explore the 
relevance of the murine hyperstimulation model to human disease, and is 
discussed in more detailed subsequently.
In fact this point of clinical relevance can be expanded to many other more 
‘clinically relevant’ models: that findings in all experimental models need to 
be confirmed by repeating experiments (where possible) with human tissue. 
Inter-species differences in PACs responses exist in animal models, and
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there is no reason to suppose that differences exist in human disease too. 
This likely explains the failure of previous human clinical trials of 
therapeutics, failing to demonstrate responses that had been shown in 
animal models. However there is still an overarching greater similarity 
between the various mammalian models, and identification of suitable 
targets for human therapeutics are much more rapidly generated by 
continued animal research. This work should be increasing undertaken in 
parallel with work on human tissue (subject to all appropriate ethical and 
legal controls).
Recent advances in basic science research have provided insight into the 
mechanisms and pathways involved. Our own group, in Liverpool, has 
shown the importance of abnormal Ca2“ signalling, in response to various 
toxins and stressors (inc. FAEE, ROS), in the development of AP (Griddle 
et al., 2006)(Petersen et al., 2011). Other important work has explored the 
role of other mechanisms, such as mitochondrial injury (Mukherjee et al., 
2008)(Gukovsky et al., 2011), and premature trypsinogen activation (Dawra 
et al., 2011).
What is clear is that AP is a very complex process, with many potential 
interacting mechanisms and pathways. The potential crossover between all
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the various participants is huge and adds to this complexity. Work must 
continue to further clarify these processes, and likely uncover previously 
unknown actions, if a therapy is to be found.
6.2 The relevance of the CCK-hyperstimulation model to human 
acute pancreatitis
The hyperstimulation model, utilising neuro-hormones such as ACh and 
CCK (or is analogue caerulein), has been controversial as an experimental 
model, due to the uncertainty surrounding clinical relevance. It is widely 
employed in both in vivo and in vitro work, partly due to reliability and 
convenience. Hyperstimulation human acute pancreatitis does exist, 
although it is rare. It occurs in exposure to a species-specific (Tityus 
trinitatis) scorpion venom and has been described in exposure to 
organophosphates. The role of CCK in commoner aetiology (i.e. gallstone 
disease and alcohol) in human AP is unclear. In addition published work 
had suggested CCK had no direct effect on isolated human PACs (Ji et al., 
2001)(Owyang et al., 2004), which seriously undermined the continued use 
of this model.
194
In Chapter 3 the direct effects of CCK-8 (and an important sub-type CCK- 
58) was explored in human tissue. Working within a collaboration our group 
definitively demonstrated that CCK-8 and CCK-58 do elicit direct responses 
from human isolated PACs (Murphy et al., 2008). This was confirmed by 
undertaking experiments in the presence of inhibitors of other neuro- 
hormonal pathways, so that responses must have been through activation of 
CCK receptors only. We found that human tissue had to be selected for 
optimal viability, which invariably meant coming from donors with 
pancreatic diseases not obstructing the pancreatic duct. We also optimised 
the transport solution and found that rapid transport to the laboratory for 
immediate preparation of cells was vital. CCK stimulation led to responses 
in isolated human tissue that closely mimicked that seen in murine PACs, 
from transient [Ca ]j spikes with physiological concentrations to elevated, 
persistent toxic signalling with hyperstimulation. It is important to show that 
these responses lead to real secretion mechanisms. This was accomplished 
experimentally by loading zymogen granules with quinacrine and 
demonstrating stimulus-metabolic-secretion coupling.
Work was also undertaken to explore differences in effects between CCK-8 
and CCK-58, as previous work had suggested that CCK-58 might be more 
physiologically relevant (Reeve et al., 2003 and 2004). Experiments in both
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human and murine PACs showed remarkably similar responses to both 
CCK-8 and CCK-58.
Taken together this work has justified the continued use of the murine 
hyperstimulation model, with CCK/caerulein, in further investigate of acute 
pancreatitis. It has also demonstrated the importance of undertaking animal 
experimental animal work in parallel with human tissue to confirm common 
mechanisms.
Future work should continue to utilise human tissue (guided by all 
appropriate ethical and legal obligations) whenever possible. Tissue slices 
may provide more useful interpretations than isolated cells, as the latter are, 
by their nature of preparation, less physiological and more prone to 
unintended injury.
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6.3 Role of Bcl-2 family proteins in acute pancreatitis
Whilst there is strong evidence that necrosis is always detrimental in acute 
pancreatitis (Pandol et ah, 2007) the role of apoptosis may not be entirely 
straightforward. For most of the last two decades it has been held that 
apoptosis is protective in pancreatitis (Bhatia et ah, 2004), which has been 
supported by experimental work. Such work included observations that 
severe AP models histologically show more evidence of necrosis (e.g. duct 
ligation in the opossum, caerulein hyperstimulation in mice), whilst milder 
AP models are found on histological examination to have evidence of more 
apoptosis (e.g. PD ligation and caerulein hyperstimulation in rats). More 
direct experimental work involved exposing murine models to agents 
known to induce apoptosis (such as l-Cyano-2-hydroxy-3-butene (CHB)) 
and then inducing AP via the caerulein model (Bhatia et ah, 1998). The 
effects of AP were ameliorated, but then it is possible that CHB could be 
acting via many other pathways and not just via the apoptotic pathway.
Apoptosis is regulated by two pathways: the extrinsic pathway (involving 
death receptor activation) and the intrinsic pathway (regulated by 
cytochrome c release and is closely linked to mitochondrial injury). These 
two pathways are not mutually exclusive, and there is cross-talk between
197
them. So numerous, complex interactions with participating agents (often 
having both positive and negative feedback behaviour) exist and the full 
extent of all these interactions is very unclear. The Bcl-2 family of proteins 
are well-known regulators of the intrinsic pathway, but recent evidence 
suggests possible action on the extrinsic pathway (He et ah, 2009). Several 
members of the Bcl-2 family have been described in terms of their apoptotic 
activity as pro-apoptotic (Bak and Bax) or pro-survival/anti-apoptotic (Bcl-2 
and Bcl-xL) (Bhatia, 2004)(Kroemer et ah, 2007). However that view is 
being recognised as possibly simplistic (Sung KF et ah, 2009)(Gukovsky et 
al., 2011). Apoptosis may not be protective in every situation. We 
undertook experiments to further investigate the role of Bak, Bax and Bcl-2 
in acute pancreatitis. It is generally believed from in vitro work that Bak and 
Bax have overlapping roles (Brooks et ah, 2007) in apoptosis and 
mitochondrial injury. Their role in mitochondrial injury, and formation of 
the mitochondrial permeability transition pore (MPTP), is important for 
optimal cytochrome c release and intrinsic pathway activation. However 
some cytochrome c release can occur in the absence of both genes (Brooks 
et al., 2007). Bak and Bax also regulate the IP3R on the endoplasmic 
reticulum surface and have important effects on Ca2+ release needed during 
apoptosis (Oakes et ah, 2005). Isolated cells deficient in Bak and Bax have 
markedly reduced stores of ER Ca2+ and have been shown to be resistant to
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Ca2+-dependent death stimuli (Oakes et al., 2005). To date no work has been 
reported in in vivo Bcl-2 family knockouts.
The work described in Chapter 4 details experiments with caerulein-induced 
acute pancreatitis in Bak, Bax and Bcl-2 KO mice. The results were contra 
to apoptosis always being protective. In Bak KO and Bax KO it was 
hypothesised that AP would be more severe and this would be related to less 
apoptosis. However in Bak KO less severe pancreatitis was found at all time 
points, and with no measurable effect on apoptotic activity as compared to 
controls. Bax KO produced an even more complex picture with more severe 
disease in the first 12 hours. There was evidence of necrosis from a very 
early time point (8 hours) but was then followed with increased apoptotic 
activity between 12 and 24 hours. These results are unexpected and difficult 
to reconcile with current understanding of cell death pathways in AP. 
Possible explanations are:
i) Bax is important in the mitochondrial response to injury and in activation 
of the intrinsic pathway of apoptosis via cytochrome c release. In Bax KO 
these roles are missing and early phase (within first 8 hours) mitochondrial 
injury is much more likely to lead to necrosis than to apoptosis. This would 
also explain why necrosis is seen on histology at 8 hours (which is not seen
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so early in any other experimental group), and why the overall severity of 
AP is higher.
ii) The increased apoptotic activity (as observed through caspase-3 IHC 
staining) may be due to activation of the extrinsic pathway of apoptosis. 
This could be triggered by the necrosis already occurring in some of the 
damaged PACs, and would suggest that under normal conditions Bax may 
even have an inhibitory function on the extrinsic pathway, that is lost in Bax 
KO. The development of necrosis leading onto extrinsic pathway activation 
would explain the time delay of apoptosis appearing by 12 hours.
ii) This is an experimental error in interpretation of the caspase-3 IHC 
staining data. The histopathological score was reasonably consistent, and 
fitted with the original hypothesis that Bax KO should develop more severe 
AP. What was surprising was the degree of apoptotic activity at 8 and 12 
hours, as measured by caspase-3 staining. The concern would be that areas 
of necrosis are staining for caspase-3 and confounding results. Histological 
appearances do not immediately suggest this, and in many slides it was 
observed that non-staining, clearly necrotic regions were adjacent to heavily 
staining, and assumed apoptotic, regions. It is possible that these heavily 
stained areas could be PACs that initiated apoptosis, but were unable to
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complete and switched to necrosis. The time points of 12 and 24 hours 
could coincide for when this switch is occurring. This would not 
immediately explain why necrosis is seen early on in histopathology, yet 
caspase-3 staining takes 12 hours to rise significantly.
The results from in vivo AP experiments in Bcl-2 family KO mice are the 
first undertaken and are intriguing. If genuine they suggest that there are any 
aspects of the roles of Bax and Bak that are not fully understood, and that 
the prevailing view that apoptosis is protective in all settings may not be 
true. Bak KO showed decrease in severity of AP, but without any significant 
change in apoptotic activity. This could be explained by relation to the 
finding in in vitro work that Bak regulates IP3R function and Bak KO leads 
to reduced Ca2t signalling, preventing toxic signalling and resistance to 
Ca2+-related death pathways (Oakes et al., 2005). Bcl-2 KO showed no 
significant change in either severity or apoptotic activity from controls. Bax 
KO showed more dramatic, and more challenging, results by demonstrating 
an increase in early severity, with necrosis, followed 12 hours later with a 
dramatic increase in apoptotic activity.
Further work is needed to clarify the roles of Bcl-2 family proteins. In 
particular the Bax gene appears to play a critical role in severity, and
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warrants farther investigation. In vitro work with Bax KO models would 
help clarify the mix of necrosis and apoptosis demonstrated in these 
experiments. Bak KO led to less severe disease do that agents that target 
Bak function would be of potential interest.
6.4 Role of caffeine as a potential therapeutic
Caffeine was investigated for its potential therapeutic value. This potential 
was derived from caffeine’s action in preventing toxic Ca signalling in 
isolated murine PACS, and (since the work described in Chapter 3) in 
isolated human PACs. Caffeine has been shown to act on the IP3R receptor 
Ca2+ channels found on the ER surface, and to a lesser extent on ZGs. Two 
subtypes, IP3R2 and IP3R3, are found in PACs (Wojcikiewicz et al., 1995), 
with IP3R2 being most critical to IP3-induced Ca2+ release (Park et al., 
2008). Our group has shown that caffeine inhibits IP3R and IP3 production 
(Wakui et al., 1990) and specific inhibition, or knockout, of IP3R markedly 
reduces toxic Ca2+ and premature trypsinogen activation in vitro 
(Gerasimenko et al., 2009).
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The work described in Chapter 5 is the first, to our knowledge, to test the 
effects on caffeine on murine experimental models of caerulein-induced 
acute pancreatitis in vivo. It was found that a doses-dependent protective 
effect of caffeine did exist in this experimental model. At a concentration of 
1 mg/kg, caffeine showed no effects on the course of caerulein-induced 
pancreatitis. However increasing the dose to 10 mg/kg showed a protective 
effect with significantly less evidence of histopathological disease at 8 
hours. There were no observable detrimental side effects in the animals at 
either of these concentrations. A higher concentration of 50 mg/kg appeared 
to be even more effective, but produced severe side-effects of caffeine 
toxicity in the animals tested and experiments with this dose were 
abandoned. Also only two animals received 50 mg/kg, so some caution 
needs to be employed when considering results from such a small group. 
Even so the preliminary findings are encouraging.
Caffeine produces its effects on Ca2+ signalling in vitro through inhibitory 
action on IP3R. This was the rationale for these in vivo experiments. 
However it is possible it acts through other pathways. Caffeine is known to 
act on phosphodiesterase (PDE) and inhibition of this pathway may be a 
factor in decreasing severity of disease, through an unknown mechanism 
(Camello et ah, 1996).
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The protective effects of caffeine need to be further explored with in vivo 
murine models. Suggestions for future work include:
i) Repeating experiments with a caffeine concentration of 20-30 mg/kg. 
This may provide further protective effect whilst keeping toxic side effects 
within acceptable levels.
ii) Repeating experiments at longer times points (either 12 and 24 hours) as 
this will demonstrate whether caffeine protection lasts over a time frame 
that caerulein-induced pancreatitis is known to progress.
iii) Measure serum caffeine levels to ensure the estimated concentration of 
about 0.5 mM is correct. This serum level may be too high for human use.
iv) Measure other parameters associated with pancreatitis both locally (e.g. 
trypsin activity) and systemically (e.g. lung histology, IL-6 levels)
v) Repeating experiments with caffeine metabolites (theophylline, 
paraxanthine, theobromine) to assess if any of these are actually producing 
the protective effect.
vi) Giving caffeine at the mid-point of the experiment, to counter any 
suggestion that it interferes with caerulein absorption when they are 
administered together.
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Caffeine represents an intriguing possible therapeutic agent for the 
treatment of acute pancreatitis. It is already used as therapeutic in neonatal 
apnoea, but much experimental work remains to clarify its mechanism and 
optimal effective dosage before human trials could be contemplated. It 
might be that a caffeine analogue may have similar protective effects, at 
much smaller concentrations, reducing the risks of toxic side effects
6.5 Future directions
Currently AP is without specific therapy, yet rapid advances have been 
made especially in the last two decades with regards to understanding of 
underlying mechanisms. This understanding has been brought in large part 
by basic science research with animal models. There is an increasing need 
for parallel work in human tissue, to validate which mechanisms translate 
across species, and thus are suitable targets for therapy. Once suitable 
agents have demonstrated efficacy in animal models they can be considered 
for the various phases of human clinical trials, and find an effective 
treatment for this common debilitating disease.
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Statement of originality
The work undertaken and described in this thesis was carried out while I 
was employed as a clinical research fellow within the Division of Surgery 
and Oncology (later School of Cancer Studies) and the Department of 
Physiology (under the Institute of translational medicine), University of 
Liverpool. Most of the experimental work was carried out between Feb 
2005 and Apr 2008. This thesis has been written entirely by myself.
The majority of experimental work was carried out by myself, except for 
some sections of Chapter 3, which were produced by joint effort within our 
collaboration. Some figures were produced by other members of our group 
and are reproduced with permission. These include figure 3.7 (Mr J Murphy 
and Dr M Chanov) and figure 3.8 (Dr J Gerasimenko). Some work in 
chapter 3 was undertaken jointly by myself and Dr D Criddle (figures 3.3, 
3.4, 3.5, 3.6 and 3.9). Serum amylase measurements were performed by the 
Department of Biochemistry and H&E slide preparation by the Department 
of Pathology at the Royal Liverpool University Hospital. Bak, Bax and Bcl- 
2 animals were originally supplied by Prof. M. Pritchard and Prof. A. 
Watson, Division of Gastroenterology. Some IHC staining was performed 
by the Department of Immunohistochemistry, University of Liverpool.
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